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Overview 
Depression is associated with deficits in the recollection of specific autobiographical 
memories, a phenomenon referred to as overgeneral memory. Neither the modifiability 
nor the neural correlates of overgeneral memory are currently well understood. The 
aim of this thesis was to increase the understanding of autobiographical memory 
specificity and overgeneral memory in depression.  
 
Part one of the thesis is a literature review investigating whether interventions for 
treating and preventing depression are effective in improving autobiographical 
memory specificity. Nineteen studies of varying methodological strength were 
identified and included in the review. There is evidence that memory specificity 
improves over the course of treatment for depression, but further research is required 
to establish the causal effects of different interventions and the effectiveness of 
prevention strategies. 
 
Part two of the thesis presents an empirical study aimed at establishing the association 
between overgeneral memory and allocentric spatial memory as a measure of 
hippocampal function in depression. Depressed and non-depressed adults completed 
measures of autobiographical memory and allocentric spatial memory. The depression 
group showed impairment in autobiographical memory, but not in allocentric spatial 
memory, and there was no association between performance on the two memory tasks. 
The data was collected in the context of a joint project (Williams, 2017). 
 
Part three of the thesis is a critical appraisal of the research. It offers reflections on 
study design and recruitment, benefits of a joint project, exclusion criteria and 
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generalizability, challenges in measuring autobiographical memory, and the role of a 
clinical researcher in the National Health Service.  
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Abstract 
 
Aims: Depression is associated with deficits in autobiographical memory specificity 
(AMS). As these deficits often persist in recovery, the modifiability of AMS has been 
debated. The aim of this review was to establish the current evidence-base for clinical 
interventions in improving AMS in the treatment and prevention of depression. 
 
Method: A systematic search of the databases PsychINFO, Medline and Embase was 
conducted to identify publications relevant to the research question. Nineteen 
controlled clinical trials and cohort studies were included in the review.  
 
Results: Of the nineteen studies meeting inclusion criteria, fifteen reported an 
improvement in AMS following the intervention. The evidence for an increase in AMS 
was stronger for treatment than prevention studies. The evidence for the relationship 
between change in AMS and depressive symptoms was mixed.  
 
Conclusions: There is evidence that AMS improves over the course of psychological 
treatment. The evidence from prevention studies is currently weak. Due to a lack of 
high-quality trials, further research is needed to establish the causal effects of 
interventions, the relative benefits of different treatments, and the relationship between 
change in AMS, depressive symptoms and other cognitive processes. 
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1.! Introduction 
 
1.1.! Autobiographical memory retrieval 
 
Autobiographical memory (AM) retrieval allows humans to mentally travel backwards 
in time and access personally experienced events from the past (Conway & Pleydell-
Pearce, 2000; Tulving, 2002). AM retrieval consists of sensory, affective and cognitive 
material, and can vary in the level of specificity and detail accessed (Piolino, 
Desgranges & Eustache, 2009; Talarowska, Berk, Maes & Galecki, 2016). The Self 
Memory System (SMS) model of AM proposes a description of the specificity of 
memories reached through a hierarchical model with three interacting levels (Conway 
& Pleydell-Pearce, 2000). The most basic level is lifetime episodes (Being at 
university), the second level is repeated categories of events (Parties at university) and 
the third, and highest level, is specific memories (Losing my bag at Jane’s party). 
When not disrupted, the SMS matches the level of specificity reached with the purpose 
of the memory search based on current goals and needs.  
 
The functions of specific AM retrieval include self-continuity, social bonding, 
problem-solving and guiding behaviours (Bluck & Alea, 2011; Conway & Pleydell-
Pearce, 2000; Talarowska et al., 2016). A number of clinical presentations are 
associated with disruptions in specific AM retrieval, including emotional disorders 
such as depression and post-traumatic stress disorder (PTSD) (Liu, Li, Xiao, Yang & 
Jiang, 2013; Williams et al., 2007). Improved understanding of AM retrieval in 
depression may provide insight for treatment and prevention of depressive disorders 
(Nader, Hardt & Lanius, 2013).  
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1.2.! Depression and autobiographical memory  
 
Depression affects over 300 million people world-wide, and is associated with vast 
individual and societal suffering and cost (World Health Organisation, 2017). The 
emotional features of the disorder include depressed mood or loss of interest and 
pleasure, but depression is also associated with cognitive changes in both the content 
and process of AM retrieval (American Psychiatric Association, 2013; Dalgleish & 
Werner-Seidler, 2014; Köhler et al., 2015). A well-replicated link between depression 
and AM is the phenomenon of overgeneral memory (OGM), or reduced AM 
specificity (AMS) (Liu et al., 2013; Ono, Devilly & Shum, 2016; van Vreeswijk & de 
Wilde, 2004; Williams et al., 2007). OGM refers to the tendency for individuals with 
depression to retrieve less memories of specific events, and instead more general 
memories of categories of events, compared to non-depressed controls (Williams & 
Broadbent, 1986). This suggests that depression is associated with truncated memory 
retrieval before the highest, specific, level of the SMS is reached (Eade et al., 2006; 
Haque, Juliana, Khan & Hasking, 2014).  
 
OGM has been replicated in a large number of studies across different depressive 
disorders (Liu et al., 2013; Ono et al., 2016; van Vreeswijk & de Wilde, 2004; 
Williams et al., 2007). The majority of studies have used the Autobiographical 
Memory Test (AMT), where participants are presented with a number of cue words, 
and for each word asked to recall a specific memory from their past within a given 
time frame (Williams & Broadbent, 1986). The number and valance of cue words, and 
the administration and time-limits, have varied between studies (Liu et al., 2013). 
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Retrieved memories are categorised as specific (events that lasted less than 24 hours), 
categorical (memories referring to a category of events), extended (events lasting 
longer than 24 hours), or omissions (no retrieval). Despite a small number of non-
replications, the overall mean effect size of the relationship between depression and 
OGM is large and found across cue words of different valance (Liu et al., 2013; 
Williams et al., 2007). Similar findings have been replicated with other measures of 
AMS (Piolino et al., 2009; Sumner, Mineka & McAdams, 2013; Raes, Hermans, 
Williams & Eelen, 2007). OGM has also been linked with trauma and PTSD, but does 
not appear to be a transdiagnostic phenomenon and is generally not found in anxiety 
disorders (Ono et al., 2016; Williams et al., 2007).  
 
Most theoretical models of OGM in depression have focused on the cognitive 
processes that may truncate AM retrieval. Williams and colleagues (2007) developed 
the CaR-FA-X model, which proposes that OGM is the result of memory retrieval 
being prematurely terminated due to a combination of capture and rumination, 
functional avoidance and deficits in executive function. This model has received 
support from a number of studies showing an association between OGM and these 
cognitive functions, although with variations in the strength of associations (Stewart, 
Hunter & Rhodes, 2017; Sumner, 2012; Sumner et al., 2014a; Williams et al., 2007). 
 
1.3.! Consequences of OGM  
 
Whilst the association between depression and OGM is well established, the causal 
relationship lacks clarity. OGM does not appear to be just a symptom of depression, 
and has been linked with a number of adverse consequences and a worse prognosis of 
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the disorder (Kleim & Ehlers, 2008; Peeters, Wessel, Merckelbach & Boon-
Vermeeren, 2002; Williams et al., 2007). OGM predicts future onset and symptoms of 
depression, and has been found both in individuals in remission and at high risk of 
depression (Liu et al., 2016; Rawal & Rice, 2012; Sumner et al., 2011; Sumner, 
Griffith & Mineka, 2010; Van Daele, Griffith, Van der Bergh & Hermans, 2014; 
Williams et al., 2007; Young, Bellgowan, Bodurka & Drevets, 2013). Talarowska and 
colleagues (2016) suggest that OGM is both a cause for, and a consequence of, 
depression, which could implicate OGM as a target in the treatment and prevention of 
depression.  
 
OGM has been linked with deficits in problem solving, goal setting, and imagining the 
future (Arie, Apter, Orbach, Yefet & Zalzman, 2008; Beaman, Pushkar, Etezadi, Bye 
& Conway, 2007; Belcher & Kangas, 2014; Polock & Williams, 2001; Raes et al., 
2005; Sarkohi, Bjärehed & Anderson, 2011; Williams et al., 2007). Reduced AMS 
may act as a risk and maintaining factor for depression due to the inability to rely on 
past experiences for problem solving (Foland-Ross & Gotlib, 2012). Repeated recall 
of general memories may also increase rumination and contribute to feelings of 
hopelessness (Hitchcock, Werner-Seidler, Blackwell & Dalgleish, 2017; Sumner et al., 
2010). 
 
OGM may impact the success of treatment for depression (Etkin, 2016). High levels 
of OGM have been linked with lower recovery rates, as well as reduced benefit from 
psychoeducation (Brittlebank et al., 1993; Van Daele, Van den Bergh, Van 
Audenhove, Raes & Hermans, 2013). The impact of OGM on goal setting and 
retention of therapeutic strategies might also influence therapeutic engagement and 
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outcomes (Harvey et al., 2016; Talarowska et al., 2016). Measuring OGM may provide 
information on whether interventions for depression are likely to be effective, and 
could contribute to guiding clinical interventions (Van Daele et al., 2013).  
 
1.4.! Is it possible to modify OGM? 
 
An implication of the CaR-FA-X model is that OGM is modifiable through targeting 
rumination, avoidance or executive function. However, evidence for a lack of decrease 
in OGM following remission, has led to suggestions of OGM being a trait or 
vulnerability marker rather than a state feature of depression (Ahern & Semkovska, 
2017; Brittlebank et al., 1993; Haddad, Harmer & Williams, 2014). Studies measuring 
OGM at different points in time suggest that OGM is moderately stable over time in 
both clinical and community samples (Hermans et al., 2008; Peeters et al., 2002; 
Sumner et al., 2014b). 
 
A number of studies suggest that OGM can be manipulated in experimental settings. 
Brief distraction procedures aimed at reducing analytic thinking have been associated 
with a decrease in OGM in depressed and non-clinical populations (Raes, Watkins, 
Williams & Hermans, 2008; Watkins & Teasdale, 2001; 2004; Watkins, Teasdale & 
Williams, 2000). OGM can also be increased by inducing ruminative thinking (Crane, 
Barnhofer, Visser, Nightingale & Williams, 2007; Watkins, Ramponi & Barnard, 
2006). Administration of hydrocortisone, which is naturally present in individuals 
under psychological stress, has been shown to increase OGM in non-depressed 
individuals (Schlosser et al., 2010; Young, Drevets, Schulkin & Erickson, 2011).  
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As OGM can be manipulated in the short term, it is possible that clinical interventions 
may also lead to changes in OGM. A number of therapeutic approaches directly target 
cognitive processes associated with OGM such as ruminative thinking and avoidance, 
including cognitive behavioural therapy (CBT) and third-wave therapies such as 
mindfulness-based cognitive therapy (MBCT) (Butler, Chapman, Forman & Beck, 
2006). Changes in OGM might also be found as a result of changes in mood, but little 
is known about the impact of clinical interventions on OGM and AMS. It is possible 
that disturbances in AM are best targeted directly through memory training (Dalgleish 
& Werner-Seidler, 2014; Young et al., 2012). There is emerging evidence that 
targeting aspects of AM, including specificity, may have beneficial effects on 
depressive symptoms (Hitchcock et al., 2017). Evidence from PTSD trials suggest 
reductions in OGM following both general interventions and interventions targeting 
memory specificity (Akbarian et al., 2015; Moradi et al., 2014; Sutherland & Bryant, 
2007). 
 
The importance of understanding the modifiability of OGM and AMS is highlighted 
by the current challenges in treating and preventing depression (Sumner et al., 2010). 
Despite the availability of a range of effective interventions, current treatments for 
depression are effective for less than 50% of individuals, and for those who recover 
relapse rates are high (De Maat, Dekker, Schoevers & De Jonge, 2006; Hollon, Thase 
& Markowitz, 2002). Effectiveness of prevention strategies for depression is less well-
established, but there is evidence that psychological interventions may prevent 
recurrent episodes or onset in individuals identified as being at high risk of developing 
depression (Biesheuvel-Leliefeld et al., 2015; Calear & Christensen, 2010; Horowitz 
& Garber, 2006; Spence & Shortt, 2007). 
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1.5.! Rationale of the review 
 
OGM is a well-replicated feature of depression, with potentially important 
implications for the development, course and reoccurrence of the disorder. Whilst 
early studies viewed OGM as a trait vulnerability marker for depression, there is 
evidence that OGM is amenable to change. OGM may be altered by established 
psychological approaches, particularly those targeting rumination and thinking style, 
or by targeted memory training. Given that OGM often persists following symptom 
reduction, it is not clear how effective current treatment and prevention strategies are 
in modifying OGM. To date, no review known to the author has investigated the 
effectiveness of treatment and preventative interventions for depression in producing 
changes in OGM/AMS. 
 
1.6.! Aim of the review 
 
The aim of this review was to establish whether clinical interventions for treating and 
preventing depression are effective in reducing OGM and improving AMS. The 
relationship between change in AMS and change in depressive symptoms was also 
considered and discussed. Due to a lack of high quality randomised controlled trials, 
along with the heterogeneity of studies, meta-analysis was not performed.  
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2.! Method 
 
2.1.! Inclusion and exclusion criteria 
 
Publications: Publications in peer-reviewed journals and available in English were 
included in the review.  
 
Studies: Intervention studies with a longitudinal design and outcome measures from 
at least two separate points in time were included in the review.  
 
Participants: Studies were included regardless of the depression status of participants 
(including depressed, formerly depressed and non-depressed). Studies were excluded 
if the participants had another primary psychiatric or neurological diagnosis.  
 
Interventions: All interventions aimed at treating or preventing depression were 
included, except electro-convulsive therapy (ECT) due to its potential negative impact 
on AM (Fraser, O’Carroll & Ebmeier, 2008). Studies in laboratory settings (such as 
single mood induction or a single dose of a substance) were excluded.  
 
Outcome measures: Studies were included if they provided a measure of AMS and a 
measure of depressive symptoms. 
 
2.2.! Search strategy 
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A systematic search to identify relevant publications was conducted using the 
databases PsychINFO, Medline and Embase. All database searches were limited to 
publications between 1986, when the initial paper on OGM was published (Williams 
& Broadbent, 1986), and 1st December 2016. Searches were also limited to 
publications in English and publications on humans.  
 
The search strategy consisted of the terms “overgeneral memory” OR 
“autobiographical memory” OR “memory specificity” cross-referenced with 
“depress*”. The medical subject headings (MeSH) “autobiographical memory” and 
“depression” were applied where these terms were available. The search terms are 
presented in Table 1. 
 
Table 1. Search terms and number of results for each database 
Search terms and number of results for each database 
  PsychINFO Medline Embase 
Autobiographical 
memory: Free text 
“autobiographical memory” OR “overgeneral memory” OR 
“memory specificity” 
Autobiographical 
memory: MeSH terms Autobiographical memory Not available 
Depression: Free text “depress*” (truncated to allow for multiple endings of the term) 
Depression: MeSH 
terms 
Depression  
(emotion) Depression 
Limits Human, English language, 1986-1 December 2016 
Number of results 852 529 649 
Total number of 
results after removing 
duplicates 
1189 
 
The reference lists of all included papers were hand-searched to identify possible 
publications missed by the database searches. The “cited by” function in Ovid was also 
used to identify papers that had cited the original paper on OGM (Williams & 
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Broadbent, 1986) or one of the most widely cited reviews of OGM (Williams et al., 
2007). 
 
2.3.! Outcome of systematic search  
 
The database searches were screened by one researcher. The referencing manager 
programme Mendeley was used to organise the results and remove duplicates. The 
database searches identified 1189 publications. The stages of the search and screening 
process are presented in Figure 1. 
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Figure 1. Flow chart of search results and screening process 
 
Publications identified by 
database searches (after 
removing duplicates): 1189 
Publications screened by 
title/abstract: 1189 
Publications screened for 
inclusion/exclusion criteria: 
39 
Publications included in the 
review: 19 (Presented in 
Table 3) 
Publications excluded: 1152 
Publications not meeting 
inclusion/exclusion criteria: 
20 
Publications identified from 
reference lists of other 
studies: 2 
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In the initial selection process, publications were excluded on the basis of the title or 
abstract. Thirty-nine publications were screened in more depth and excluded if they 
did not meet the inclusion criteria (for example, not a clinical intervention, not 
measuring AMS, population with a different psychiatric diagnosis). One study, 
investigating the effect of MBCT on specificity of life goals, was excluded as it, 
despite measuring AMS at two points in time, only reported its correlational 
relationship with specificity of life-goals and not the outcomes of AMS (Crane, 
Winder, Hargus, Amarasinghe & Barnhofer, 2012). Nineteen studies met the inclusion 
criteria and were included in the review. 
 
2.4.! Data extraction 
 
One researcher extracted the relevant study, population and intervention 
characteristics. A data extraction template was developed for the purpose of this 
review and included: 
•! Publication details 
•! Study location 
•! Study design  
•! Participant demographics 
•! Depression status 
•! Details of intervention 
•! Details of control condition (where applicable) 
•! Outcome measures  
•! Data analysis 
•! Outcomes 
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2.5.! Quality assessment 
 
One researcher rated the methodological quality of the included studies using the 
Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for 
Quantitative Studies (available at http://www.ephpp.ca/tools.html) (Thomas, Ciliska, 
Dobbins & Micucci, 2004). The EPHPP Quality Assessment Tool for Quantitative 
studies was developed to help researchers establish the quality of public health 
interventions when conducting systematic reviews, and has excellent inter-rater 
agreement (Armijo-Olivo, Stiles, Hagen, Biondo & Cummings, 2012). It was chosen 
for this review as it can be used across different study designs, and produces overall 
study ratings of weak, moderate or strong, which are easily accessible to the reader. 
Due to lack of high-quality trials regarding the current research question, no studies 
were excluded on the basis of the quality ratings. Quality was instead considered in 
the interpretation of the results. 
 
The EPHPP Quality Assessment Tool for Quantitative Studies rates study quality 
across six domains including selection bias, study design, confounders, blinding, data 
collection methods, and withdrawal and drop-out rates. Each domain is given a rating 
of weak, moderate or strong based on a number of criteria. The component ratings are 
then used to give the study an overall quality rating of weak (two or more weak 
ratings), moderate (less than four strong ratings, not more than one weak rating) or 
strong (at least four strong ratings, no weak ratings). The tool also includes questions 
on intervention integrity and analysis, which are not used in the overall rating of study 
quality. 
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3.! Results 
 
3.1.! Study design and quality assessment 
 
3.1.1.! Study design  
 
The study designs for the nineteen studies included in the review were categorised 
using the EPHPP Quality Assessment Tool for Quantitative Studies (Thomas et al., 
2004). Due to an absence of descriptions of the randomisation process in controlled 
studies, none of the studies qualified as a Randomised Controlled Trial (RCT). The 
study designs included controlled clinical trials (CCTs) (n=12), controlled cohort 
analytic trials (n=3) and uncontrolled cohort trials (n=4). The majority of control 
conditions consisted of no intervention or treatment as usual (TAU).  
 
All studies included measures from before and after the interventions. The times 
between the assessments varied depending on the length of the intervention, which 
ranged from one (Mogoaşe, Brăilean & David, 2013) to twenty weeks (Boritz, Angus, 
Monette & Hollis-Walker, 2008). Five studies included additional follow-up 
assessment of AMS and depression, and two of depression only. 
 
3.1.2.! Quality assessment 
 
The component and overall quality ratings of the included studies are presented in 
Table 2. Of the nineteen studies, five studies were given an overall rating of strong, 
eleven studies of moderate and three studies of weak.  
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Table 2. Quality assessment of included studies using the EPHPP Quality Assessment Tool for Quantitative Studies 
Quality assessment of included studies using the EPHPP Quality Assessment Tool 
for Quantitative Studies 
 
 
The CCTs were rated as strong for study design, and the cohort studies as moderate. 
Four studies were rated as strong on selection bias, and the rest as moderate or weak 
due to potential of bias in the recruitment process or lack of reporting. Where a control 
group was used, most studies were rated as strong on confounders. Three studies 
received a rating of weak due to group differences not being described or controlled 
for in the analysis. Double-blinding was not clearly described in any of the studies. 
The majority of studies were single-blind with the assessor being unaware of the 
condition of participants, and studied were rated as moderate or weak on blinding. 
Despite the AMT not being a standardised measure, its validity and reliability have 
been demonstrated (Griffith et al., 2012; Williams et al., 2007). For the purpose of this 
review, studies using the AMT and an established measure of depression symptoms 
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were given a rating of strong for data collection methods. Other measures of AMS 
were rated as moderate or weak. Ten studies were rated as strong on withdrawals and 
drop-outs, the rest receiving a rating of moderate or weak based on the reported drop-
out rates or a lack of description. The overall quality ratings in the EPHPP assessment 
tool do not include data analysis, and it is worth noting that a weakness of the studies 
overall was a lack of intention to treat analysis. 
 
3.2.! Study characteristics 
 
Key information about each of the included studies is presented in Table 3. The 
nineteen studies included in the review were published between 2000 and 2017. 
 
3.2.1.! Demographic characteristics 
 
The sample sizes of studies ranged from 10 to 227, with a total number of participants 
across studies of 1051. Two studies were aimed at adolescents (Neshat-Doost et al., 
2013; Rice et al., 2015), and two studies at undergraduate university students (Maestas 
& Rude, 2012; Mogoaşe et al., 2013). Five studies recruited older adults, with the mean 
age ranging from 65.35 to 80.7 (Gonçalves, Albuquerque & Paúl, 2009; Latorre et al., 
2015; Ramírez, Ortega, Chamorro & Colmenero, 2014; Serrano, Latorre, Gatz & 
Montanes, 2004; Serrano Selva et al., 2012). The remaining ten studies were targeted 
at adults, with the mean ages ranging from 39.64 to 54.28.  
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Table 3. Description of study characteristics and findings 
Description of study characteristics and findings 
Study 
Study 
design 
Participants 
and setting 
Depression 
status/history Gender Age Intervention 
Control 
condition Measures 
Statistical 
design 
Main 
findings 
Williams et al. 
(2000) 
Controlled 
clinical trial 
N=45 
Adults 
Recruited from 
Community 
Mental Health 
Services 
 
United 
Kingdom 
 
Remission from 
depression. 
 
At least 2 
previous 
episodes, most 
recent within 2 
years 
33 female 
12 male 
M=44.0 
SD=9.5 
 
MBCT TAU  AMT 
 
HRS-D 
ANCOVA 
♦! 
Serrano et al. 
(2004) 
Controlled 
clinical trial 
N=43 
Older adults 
Recruited 
through social 
services 
 
Spain 
 
Symptoms of 
depression 
33 female 
10 male 
M=77.19 
SD=7.68 
LRT 
 
No 
intervention 
AMT 
 
CES-D 
ANOVA 
♦! 
McBride et al. 
(2007) 
Controlled 
clinical trial 
(two 
treatment 
groups) 
 
N=42 
Adults 
 
Canada 
Diagnosis of 
depression 
29 female 
13 male 
M=40.71 
SD=10.79 
CBT 
Pharmacotherapy 
 AMT  
 
BDI-II 
ANOVA 
♦! 
Boritz et al. 
(2008) 
Cohort 
(analytic) 
N=34 
Adults 
 
Canada 
Diagnosis of 
depression 
25 female 
9 male 
M=39.64 
SD=11.97 
EFT 
PCT 
 Analysis of 
therapy 
transcripts 
 
SCID, BDI 
Hierarchical 
linear 
modelling 
analysis 
♦ 
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Study 
Study 
design 
Participants 
and setting 
Depression 
status/history Gender Age Intervention 
Control 
condition Measures 
Statistical 
design 
Main 
findings 
Gonçalves et al. 
(2009) 
Controlled 
clinical trial 
N=22 
Attendees of 
social day-care 
centre 
 
Portugal 
 
Symptoms of 
depression 
All female M=80.7 
SD=4.5 
LRT 
 
No 
intervention 
AMT 
 
GDS 
 
T-tests 
♦! 
Heeren et al. 
(2009) 
Cohort 
(analytic) 
N=36 
Adults  
 
Belgium 
 
No depression 30 female 
6 male 
M=54.28 
SD=13.62 
MBCT No 
intervention 
 AMT  
 
BDI-II 
ANOVA 
♦! 
Raes et al. 
(2009) 
Cohort (one 
group 
pre+post) 
N=10 
Psychiatric 
inpatients 
 
Belgium 
 
Symptoms of 
depression 
All female M=47.40 
SD=7.56 
MeST 
 
 AMT, 
SCEPT 
 
MDQ, BDI-
II 
 
ANOVA 
♦! 
Hargus et al. 
(2010) 
Controlled 
clinical trial 
N=27 
Adults 
 
United 
Kingdom 
Depression and 
past suicidal 
crisis 
 
At least 3 
previous 
episodes of 
depression 
 
18 female 
9 male 
M=41.89 
SD=10.47 
MBCT TAU ReSSI 
 
SCID, BDI-
II 
ANOVA 
 ♦! 
Maestas & 
Rude (2012) 
Controlled 
clinical trial 
N=207 
College students 
 
United States 
No depression 70% female 
30% male 
M=20.9 
SD=1.77 
Specific 
expressive writing 
 
Traditional 
expressive writing 
 
Control 
writing 
 AMT 
 
BDI 
ANCOVA 
ANOVA 
 ♦! 
FU  
(6 months): 
♦! 
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Study 
Study 
design 
Participants 
and setting 
Depression 
status/history Gender Age Intervention 
Control 
condition Measures 
Statistical 
design 
Main 
findings 
Serrano Selva 
et al. (2012) 
Controlled 
clinical trial 
N=37 
Older adults 
 
Spain 
 
Symptoms of 
depression 
31 female 
6 male 
M=73.9 LRT 
 
 
 
Supportive 
therapy 
AMT 
 
MINI 
 
 
PROC 
MIXED  
 
 
 
 
♦! 
 
FU (6 weeks 
and 6 
months): 
♦! 
Jermann et al. 
(2013) 
Controlled 
clinical trial 
N=36 
Adults  
 
Switzerland 
Remission from 
depression 
 
At least 3 
previous 
episodes 
25 female 
11 male 
M=46.8 
SD=10.5 
MBCT TAU  AMT  
 
MADRS, 
BDI-II 
 
 
ANOVA 
 
 
 
♦! 
 
FU  
(9 months): 
♦! 
Neshat-Doost 
et al. (2013) 
Controlled 
clinical trial 
N=23 
Bereaved 
refugee 
adolescents 
from 
Afghanistan 
(recruited 
through school) 
 
Iran 
 
Symptoms of 
depression 
11 female 
12 male  
M=14.88 
SD=1.89 
MeST 
 
 
No contact AMT 
 
MFQ 
ANOVA 
 
Hierarchical 
regression 
 
 
♦! 
 
FU  
(3 months):  
! 
Mogoaşe et al. 
(2013) 
Controlled 
clinical trial 
N=42 
Undergraduate 
students 
 
Romania 
Dysphoria 40 female 
2 male 
M=22.87 
SD=4.27 
Concreteness 
training  
WL AMT 
 
BDI-II 
ANOVA 
♦! 
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Study 
Study 
design 
Participants 
and setting 
Depression 
status/history Gender Age Intervention 
Control 
condition Measures 
Statistical 
design 
Main 
findings 
Ramírez et al. 
(2014) 
Controlled 
clinical trial 
N=46 
Older adults 
attending 
Citizens’ Day 
Centre 
 
Spain 
No depression 29 female 
17 male 
M=71.18 
SD=7.06 
LRT/positive 
psychology group 
Positive 
psychology 
group 
 
AMT  
 
BDI 
ANOVA 
 
 ♦! 
 
FU (3 and 9 
months): 
♦! 
Latorre et al. 
(2015) 
Controlled 
clinical trial 
 
N=55 
Older adults 
Recruited 
though adult 
education 
courses 
 
Spain 
 
No depression 18 female 
37 male 
M=65.35 
SD=8.45 
LRT 
 
Media 
workshop 
AMT 
 
CES-D 
 
ANOVA 
ANCOVA ♦! 
 
Rice et al. 
(2015) 
Cohort 
(analytic) 
N=227 
Students 
recruited in 
schools 
 
United 
Kingdom 
 
 
No depression 124 female 
122 male 
13-14 TRY 
CBT 
MBCT 
 
 
No 
intervention 
SCEPT 
 
MFQ 
Linear 
random 
effects 
regression 
models 
 ♦! 
 
Hitchcock et al. 
(2016) 
Cohort (one 
group 
pre+post) 
N=38 
Adults 
 
United 
Kingdom 
 
Remission from 
depression 
30 female 
8 male 
M=44.32, 
SD=14.50 
MemFlex   AMT , 
 
BDI-II 
Repeated 
measures 
MANOVA ♦! 
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Study 
Study 
design 
Participants 
and setting 
Depression 
status/history Gender Age Intervention 
Control 
condition Measures 
Statistical 
design 
Main 
findings 
Sabatelli (2016) Cohort (one 
group 
pre+post) 
N=55 
Adults 
 
United 
Kingdom 
Depression and 
AMT score of 
less than 0.70 
50% female 
50% male 
M=37.90 
SD=8.79 
MeST  "AMT  
 
BDI-II 
ANOVA 
♦! 
FU  
(3 months): 
♦! 
Eigenhuis et al. 
(2017) 
Cohort (one 
group 
pre+post) 
N=26 
Outpatients 
 
Netherlands 
Depression 57.7% 
female 
42.3% male 
M=41.7 
SD=9.8 
MeST  AMT  
 
BDI-II, 
MADRS 
T-tests 
♦! 
 
FU (3 and 9 
months): 
 
! 
M: Mean, SD: Standard deviation, FU: Follow-up. Interventions: CBT: Cognitive behavioural therapy; EFT/PCT: Emotion focused therapy/person centred therapy; LRT: Life review 
therapy; MBCT: Mindfulness-based cognitive therapy; MeST: Memory specificity training; MemFlex: Memory flexibility training; TAU: Treatment as usual; TRY: Thinking about reward 
for young people; WL: Wait-list Autobiographical memory measures: AMT: Autobiographical Memory Test; SCEPT: Sentence completion for events from the past test; ReSSI: Relapse 
Specificty Signature Interview Depression measures: BDI: Beck Depression Inventory; CES-D: Centre of Epidemiological Studies – Depression; GDS: Geriatric Depression Scale; HRD-S: 
Hamilton Rating Scale for Depression; MADRS: Montgomery-Asberg Depression Scale; MFQ: Mood and Feelings Questionnaire; MINI: Mini International Neuropsychiatric Interview; 
MDQ: Major depression questionnaire; SCID: Structured Clinical Interview for DSM disorders 
♦ Statistically significant change in AMS compared to control group ♦Statistically significant change in AMS (no control group) ♦No statistically significant 
change in AMS 
!Statistically significant change in depression symptoms compared to control group ! Statistically significant change in depression symptoms (no control group) 
!No statistically significant change in depression symptoms "Different sets of AMT cue word used at different time-points 
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Two studies only included women (Gonçalves et al., 2009; Raes, Williams & 
Hermans, 2009), and across studies 66% of the participants were female. The majority 
of studies were conducted in Europe, and participants were predominantly White 
Europeans. 
 
3.2.2.! Depression status 
 
Ten studies were treatment studies targeting individuals with a current diagnosis or 
symptoms of depression, and nine studies were prevention studies for individuals 
without current symptoms of depression. Of the prevention studies, four targeted 
individuals in remission or with sub-clinical symptoms, whereas five targeted 
individuals without an identified risk for depression. 
 
3.2.3.! Overview of measures used 
 
The Autobiographical Memory Test (AMT) 
 
Sixteen of the studies used the Autobiographical Memory Test (AMT) originally 
developed by Williams and Broadbent (1986). The operational definition of change in 
AMS in this review refers to the number of memories categorised as specific.  
 
The AMT is described in the Introduction of this review. Administration of the AMT 
included verbal, written and computerised versions of the task and was delivered in a 
number of different languages. The number of cue words used ranged from ten to 
eighteen. Where a novel set of cue words was used, studies reported the selection 
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method for these. Seven studies used only positive and negative cues, whilst the rest 
also included neutral words. The retrieval time-limit ranged from 30 seconds to 
unlimited time. Six studies specified having used different sets of cue words at 
different measurement times (Heeren, Van Broeck & Philippot, 2009; Hitchcock et al., 
2016; Jermann et al., 2013 Maestas & Rude, 2012; Sabatelli, 2016; Williams, 
Teasdale, Segal & Soulsby, 2000). The rest of the studies either used the same set of 
cue words, or did not include details of the word lists used. 
 
Alternative measures of AMS 
 
Four studies used alternative measures of AMS. One study analysed transcripts of six 
therapy sessions, with narrative sequences identified and categorised as specific, 
generic or extended events (Boritz et al., 2008). A second study used a semi-structured 
interview regarding warning signs for a past suicidal crisis (Relapse Signature of 
Suicidality Interview; ReSSI) (Hargus, Crane, Barnhofer & Williams, 2010). 
Participants’ symptom descriptions were classified as specific, extended or categorical 
using the AMT criteria. One study used the Sentence Completion for Events from the 
Past Test (SCEPT; Raes et al., 2007) (Rice et al., 2015). Participants were provided 
with eleven sentence stems to complete, all developed to probe a memory from the 
past (e.g. I will never forget…) and responses were classified using AMT criteria. The 
SCEPT was also used by Raes and colleagues (2009) in addition to the AMT.  
 
Depression symptoms 
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A number of validated self-report measures of depressive symptoms were used and are 
presented in Table 3. As only two studies reported change in diagnostic criteria, but 
all studies reported change in self-report depression symptoms, the self-report scores 
were used to assess change in symptoms in this review.  
 
3.3.! Interventions targeting AMS: Description of interventions and outcomes 
 
Descriptions of interventions and outcomes are organised based on whether they were 
general depression interventions or interventions designed to target AMS, and whether 
they were aimed at treatment or prevention of depression. 
 
Eleven studies investigated the effectiveness of interventions designed to target AMS, 
including seven treatment studies and four prevention studies. The outcomes of these 
studies are presented in Table 4. 
 
3.3.1.! Interventions targeting AMS: Treatment studies 
 
Three CCTs explored the effect of Life Review Therapy (LRT) for older adults with 
depression (Gonçalves et al., 2009; Serrano et al., 2004; Serrano Selva et al., 2012). 
The LRT protocol used in the studies was developed by Serrano and colleagues (2004) 
to improve retrieval of positive specific memories. All three studies used a similar 
structure of four to six weekly individual sessions, with each session focusing on 
autobiographical retrieval practice for a particular life period. 
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Table 4. Outcomes of interventions targeting AMS 
Outcomes of interventions targeting AMS 
Study  
Intervention 
(T/P) Assessment times 
Change in 
AMS 
Change in 
depression 
symptoms 
Association between 
change in AMS and 
depression 
Mediation of AMS 
on depression 
symptoms 
Relationship between AMS 
change and other cognitive 
outcomes 
Serrano et al. (2004) LRT (T) 
 
Pre + post ♦ ♦ 
 
♦ ♦  
Gonçalves et al. (2009) LRT (T) 
 
Pre + post ♦ ♦ 
 
!" -  
Raes et al. (2009) MeST (T) Pre + post ♦ ♦ - - Changes in AMS correlated 
with changes in rumination, 
experiential avoidance and 
problem-solving. 
Ramírez et al. (2009) 
 
 
LRT (P) Pre + post 
4 month FU 
♦ 
♦ 
♦ 
♦ 
 
- -  
Maestas & Rude (2012) Creative 
writing (P) 
Pre 
1 month FU 
6 month FU 
 
♦ 
♦ 
♦ 
♦ 
♦ - Avoidance mediated change 
in AMS. Rumination did not 
mediate change in AMS. 
 
        
Serrano Selva et al. 
(2012) 
LRT (T) Pre+post 
6 week FU 
6 month FU 
 
♦ 
 
♦ 
 
♦ -  
Neshat-Doost et al. 
(2013) 
MeST (T) Pre + post 
2 month FU 
 
♦ ♦ 
♦ 
 
♦ ♦  
Latorre et al. (2015) LRT (P) Pre + post 
 
♦ ♦ ♦   
Hitchcock et al. (2016) MemFlex (P) 
 
 
 
♦ ♦ - -  
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Study  
Intervention 
(T/P) Assessment times 
Change in 
AMS 
Change in 
depression 
symptoms 
Association between 
change in AMS and 
depression 
Mediation of AMS 
on depression 
symptoms 
Relationship between AMS 
change and other cognitive 
outcomes 
Sabatelli et al. (2016) MeST (T) Pre + post 
3 month FU 
 
♦ 
♦ 
♦ 
♦ 
 
- -  
Eigenhuis et al. (2017) MeST (T) Pre + post 
3 month FU 
♦ ♦ 
♦ 
 
- -  
T: Treatment, P: Prevention, FU: Follow-up, LRT: Life review therapy, MeST: Memory specificity training, MemFlex: Memory flexibility programme ♦: Statistically 
significant change/association, ♦: Statistically significant change but no control group, ♦: No statistically significant change/association -: No statistical analysis reported 
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The two initial studies found an increase in AMS and a decrease in depressive 
symptoms following LRT compared to TAU (Gonçalves et al., 2009; Serrano et al., 
2004). Serrano and colleagues also reported a trend in change in AMS predicting post-
intervention depression scores, but no evidence for AMS as a mediator for the change. 
 
The first LRT study had a strong quality rating (Serrano et al., 2004) whilst the second 
study was given a moderate rating due to a lack of description of selection procedures 
and blinding (Gonçalves et al., 2009). The third LRT study included a placebo control 
group receiving supportive therapy, and additional follow-up assessments (Serrano 
Selva et al., 2012). AMS increased and depression scores decreased in both conditions, 
but there were no differences in these changes between the groups. Using only data of 
individuals who completed the measures at six-month follow-up, there was some 
support for AMS scores increasing over time in the intervention group, and evidence 
of improvement in AMS being associated with change in depression scores. Due to 
high drop-out rates before follow-up, these analyses can only be considered to be of 
moderate quality. 
 
Four treatment studies used the Memory Specificity Training (MeST) programme 
(Eigenhuis, Seldenrijk, van Schaik, Raes & van Oppen, 2017; Neshat-Doost et al., 
2013; Raes et al., 2009; Sabatelli, 2016). MeST was developed by Raes and colleagues 
(2009) to improve AMS through memory practice of both positive and negative 
memories. MeST is delivered in a group format over four to five sessions, and includes 
psychoeducation and training in recalling specific events.  
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MeST has been evaluated in three uncontrolled trials and one CCT. The initial 
uncontrolled pilot study of psychiatric inpatients suggested an increase in AMS 
measured by both the AMT and the SCEPT (Raes et al., 2009). Depression symptoms 
also decreased, and analysis showed that change in AMS correlated with changes in 
rumination, experiential avoidance and problem-solving. However, this could have 
been due to an overall decrease in depression symptoms, and the study rating was weak 
due to potential of selection bias, a small sample size, lack of blinding, high drop-out 
rates, and the possibility that other psychiatric treatments may have influenced the 
outcomes. Two further uncontrolled trials investigated the effect of MeST in depressed 
outpatients, one as a stand-alone treatment (Eigenhuis et al., 2017) and one in 
conjunction with CBT techniques (Sabatelli, 2016). In both studies, the intervention 
led to an increase in AMS and a reduction in depressive symptoms which persisted at 
three-month follow-up. The quality ratings for these studies were moderate, and in 
both studies other interventions received simultaneously may have impacted the 
results, which limits the conclusions that can be drawn about the effectiveness of 
MeST. The study by Sabatelli (2016) was the only study with OGM as an inclusion 
criteria, with all participants initially scoring less than 70% for memory specificity on 
the AMT. 
 
The CCT of MeST recruited depressed adolescent refugees from Afghanistan, some 
of whom also had symptoms of PTSD (Neshat-Doost et al., 2013). Compared to the 
control condition that received no intervention, participants showed an increase in  
AMS. A difference in depression symptoms was not present following the 
intervention, but found at two-month follow-up. Analysis suggested that change in 
AMS independently predicted follow-up depression, and that the change in AMS 
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mediated the relationship between group allocation and follow-up depression. This 
study received an overall rating of strong, and is the only study on MeST that included 
a control condition. However, due to the limited sample size, and the lack of an active 
control condition, generalisations should be made with caution. 
 
3.3.2.! Interventions targeting AMS: Prevention studies 
 
One prevention study targeted individuals in remission from depression (Hitchcock et 
al., 2016). In this uncontrolled trial, participants took part in the Memory Flexibility 
(MemFlex) programme, which consisted of an orientation session, followed by six 
work-book based sessions that participants completed at home over one month. The 
workbook included training exercises to develop the ability to balance and alternate 
between different types of thoughts and to elaborate details of memories. Participants 
showed an improvement in AMS, and no change in depressive symptoms. However, 
the study did not include a control group which, in addition to lack of clarity about 
potential selection bias and lack of blinding, meant that the study quality was rated as 
weak.  
 
The final three prevention studies recruited participants without an identified risk of 
depression. Two CCTs investigated the effect of Serrano and colleagues’ (2004) LRT 
protocol for older adults without depressive symptoms compared to an active control 
condition (Latorre et al., 2015; Ramírez et al., 2014). Ramírez and colleagues (2014) 
randomised participants to take part in either nine weeks of a LRT/positive psychology 
group, or a positive psychology group. The results suggested an increase in AMS and 
a decrease in depressive symptoms in the intervention group compared to the control 
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conditions. However, these effects were no longer present at four-month follow-up, 
and due to a high risk for selection bias the study had a moderate quality rating. In the 
study by Latorre and colleagues (2015), which had an overall quality rating of strong, 
participants were allocated to either six sessions of individual LRT or to a six-week 
media workshop. The results showed an increase in AMS and a decrease in depressive 
symptoms in the intervention group compared to the control condition. The change in 
AMS scores was not related to change in depression scores.  
 
The final prevention study recruited undergraduate students who were allocated to 
either a traditional expressive writing condition, a specific expressive writing 
condition or a control writing condition (Maestas & Rude, 2012). All groups engaged 
in a writing task for twenty minutes over three consecutive days. One month after the 
intervention there was no difference between the groups, but at six-month follow-up 
both the traditional and specific writing had led to an increase in AMS compared to 
the control condition. There was no difference in depressive symptoms between 
groups. The study also included measures of rumination and avoidance, and analysis 
suggested that whilst rumination at post-intervention did not mediate follow-up AMS, 
avoidance partially did. The authors suggested that the delay in change in AMS was 
due to initial change in avoidance following the intervention. The study quality was 
rated as strong, and the sample size in this study was large. 
 
3.3.3.! Interventions targeting AMS: Summary of outcomes 
 
All eleven studies targeting memory specificity showed evidence of improvement in 
AMS. In one of these studies, the improvement was equivalent in the intervention and 
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control condition. The results, however, should be interpreted cautiously as four of the 
studies showing an increase in AMS were uncontrolled trials, and only three of the 
controlled trials received a strong quality rating. In the treatment studies, there was 
evidence of a decrease in depressive symptoms following the interventions. Results 
regarding the association between change in AMS and in depression symptoms were 
inconsistent. As only two studies included analysis of other cognitive functions, there 
is no consistent evidence for the relationship between change in AMS and other 
cognitive processes.  
 
3.4.! General depression interventions: Description of interventions and 
outcomes 
 
Eight studies investigated the effectiveness of general depression interventions, 
including three treatment studies and five prevention studies. The results of these 
studies are presented in Table 5. 
 
3.4.1.! General interventions: Treatment studies 
 
One study randomised adults with depression to sixteen weeks of individual CBT or 
pharmacological treatment (McBride, Segal, Kennedy & Gemar, 2007). The results 
showed that both interventions led to an increase in AMS, and a decrease in depressive 
symptoms. There were no differences between the two treatment groups, and the study 
had an overall rating of moderate due to lack of reporting across a number of domains. 
It is worth noting that in most other treatment studies the TAU condition included use 
of pharmacological treatment for depression. 
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Table 5. Outcomes of general interventions 
Outcomes of general interventions 
Study  Intervention (T/P) 
Assessment 
times 
Change in 
AMS 
Change in 
depression 
symptoms 
Association between 
change in AMS and 
depression symptoms 
Mediation of AMS 
on depression 
symptoms 
Relationship between 
AMS and other 
cognitive outcomes 
Williams et al. (2000) MBCT (P) Pre + FU 
(mean: 4 
months) 
 
♦ ♦  
 
  
McBride et al. (2007) CBT/ 
Psychopharmacology 
(T) 
 
Pre + post  ♦ ♦    
Boritz et al. (2008) EFT/PCT (T) Early, mid 
and late 
therapy 
 
♦ - ♦   
Heeren et al. (2009) MBCT (P) Pre + post ♦ - ♦  Cognitive inhibition did 
not mediate change in 
AMS. Cognitive 
flexibility partially 
mediated change in 
AMS. 
 
Hargus et al. (2010) MBCT (T) Pre + post 
 
♦ 
 
♦ ♦   
Jermann et al. (2013) MBCT (P) Pre+post 
9 month FU 
♦ 
♦ 
 
♦ 
♦ 
   
Mogoaşe et al. (2013) Concreteness training 
(P) 
Pre + post 
 
♦ ♦    
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Study  Intervention (T/P) 
Assessment 
times 
Change in 
AMS 
Change in 
depression 
symptoms 
Association between 
change in AMS and 
depression symptoms 
Mediation of AMS 
on depression 
symptoms 
Relationship between 
AMS and other 
cognitive outcomes 
Rice et al. (2015) MBCT/CBT/TRY Pre + post 
 
♦ ♦    
T: Treatment, P: Prevention, FU: Follow-up; MBCT: Mindfulness-based cognitive therapy, CBT: Cognitive behavioural therapy, EFT: Emotion-focused therapy, PCT: 
Person-centred therapy, TRY: Thinking about reward for young people ♦: Statistically significant change/association, ♦: Statistically significant change but no control 
group, ♦: No statistically significant change/association -: No statistical analysis reported 
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Hargus and colleagues (2010) randomised adults with depression, at least three 
previous depressive episodes, and a history of a suicidal crisis, to an eight week MBCT 
programme (Segal et al., 2002) or TAU. AMS was measured through coding 
transcripts from a semi-structured interview for events associated with the lead-up to 
the crisis (Relapse Signature of Suicidality Interview; ReSSI). 
 
In the control group, the specificity of answers on the ReSSI decreased. In the 
intervention group, however, there was no decrease, suggesting a benefit of the 
intervention. The authors proposed that the sustained ability to recall the context 
around the past suicidal crisis may contribute to earlier recognition of warning signs 
in the future. There was also a decrease in depressive symptoms in the intervention 
group compared to the control group. There was a correlational relationship between 
change in depressive symptoms and change in relapse signature specificity across the 
two conditions, but this association was not present in the intervention group alone. 
Due to a potential of selection bias, lack of blinding and the use of a new measure of 
AMS, the study quality rating was moderate.  
 
Boritz and colleagues (2008) investigated how the disclosure of specific events 
changes over the course of Emotion Focused Therapy and Person Centred Therapy. 
Both groups received therapy once a week for 15-20 weeks. For each participant, the 
content of six therapy sessions from different stages of therapy were transcribed and 
rated on specificity. The analysis showed an increase in disclosures of specific 
memories over the course of therapy in both groups. There was no difference in 
disclosure of specific memories between individuals who did and did not recover from 
depression. Due to the measurement methodology, it is not possible to establish 
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whether the changes reflect change in AMS ability, or the development of the 
therapeutic process, and due to a lack of reporting across a number of study features 
the overall quality rating of this study was weak. 
 
3.4.2.! General interventions: Prevention studies 
 
Two studies investigated the effect of MBCT in individuals in remission from 
recurrent depression (Jermann et al., 2013; Williams et al., 2000). Both studies used a 
standard MBCT protocol of eight weekly sessions (Segal, Williams & Teasdale, 2002).  
 
Williams and colleagues’ (2000) study was rated as strong, and found an increase in 
memory specificity. This was not replicated by Jermann and colleagues (2013), whose 
study was rated as weak due to high attrition rates and lack of clarity around 
confounding factors. Neither study found a change in depression scores. A third study, 
using a similar MBCT protocol, recruited adults without an identified risk of 
depression, and compared them to matched controls (Heeren et al., 2009). The results 
suggested an increase in AMS following the intervention compared to the control 
group. No difference in depressive symptoms was found. Due to a lack of 
randomisation, and lack of reporting on selection bias and blinding, the overall quality 
of this study was moderate.  
 
Mogoaşe and colleagues (2013) investigated the effectiveness of a seven-day online 
concreteness training programme for undergraduate students with symptoms of 
dysphoria. Participants completed daily exercises aimed to facilitate and develop 
concrete thinking using hypothetical scenarios. The study, which had a quality rating 
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of moderate, did not find a benefit of the intervention on AMS or symptoms of 
depression.  
 
The largest study in the review was a controlled cohort study investigating the effects 
of depression prevention intervention in schools (Rice et al., 2015). Three eight-week 
prevention programmes, including CBT, MBCT and a reward processing intervention, 
were compared to a control condition receiving no intervention. None of the conditions 
showed a benefit on AMS or on depressive symptoms compared to the control group. 
Due to the study design, lack of reporting on blinding, and the use of SCEPT, the 
overall study rating was moderate. 
 
3.4.3.! General interventions: Summary of outcomes 
 
Of the eight studies investigating the effect of general depression interventions, five 
showed a benefit on AMS and three did not. All treatment studies showed an increase 
in AMS, but due to the quality of the studies and and variability in interventions and 
methodologies for assessing AMS, few conclusions can be drawn. There was mixed 
evidence for MBCT improving AMS in prevention studies. The general interventions 
provided no evidence for a relationship between change in AMS and change in 
depression symptoms, and only one study examined the association between AMS and 
change in other cognitive factors. 
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4.! Discussion 
 
The aim of this review was to establish the current evidence-base for clinical 
interventions in improving AMS in the treatment and prevention of depression. The 
evidence from the studies is summarised and discussed, followed by methodological 
considerations, implications of the findings, and a summary of the limitations of this 
review. 
 
4.1.! Summary of findings 
 
4.1.1.! Do interventions for depression improve AMS? 
 
Of the nineteen studies included in the review, fifteen reported an increase in AMS 
following the intervention, one study equivalent improvements in the intervention and 
control condition, and three studies no change in AMS. All treatment studies were 
associated with changes in AMS, with the three studies reporting no change all being 
prevention studies. Despite these promising results, study design and quality pose 
limitations to the causal attributions of the interventions. Of the nineteen studies, seven 
were uncontrolled trials, and only five of the controlled trials had an overall quality 
rating of strong. Whilst the effectiveness of interventions needs to be further 
considered, the results strongly support that OGM in depression should be viewed as 
a modifiable rather than stable trait (Brittlebank et al., 1993). This is consistent with 
the predictions of the CaR-FA-X model, which suggests that change in cognitive 
processes can be associated with change in AMS (Williams et al., 2007), and with 
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emerging evidence of AMS being modifiable in other psychiatric conditions (Moradi 
et al., 2014; Ricarte, Hernández-Viadel, Latorre, Ros & Serrano, 2014). 
 
For treatment studies, a larger number of higher quality trials were available for 
interventions targeting AMS than for general depression interventions. The strongest 
evidence came from the controlled trials of LRT in older adults, with LRT leading to 
an increase in AMS in four trials, and the final trial finding equivalent benefits of LRT 
and supportive therapy. There was preliminary evidence for MeST improving AMS in 
four studies, but only one of these was a controlled clinical trial, and a significant 
weakness in the uncontrolled studies was the possibility of other treatment strategies 
influencing the outcomes. The encouraging results from the uncontrolled studies 
targeting memory need to be interpreted cautiously as improvements in AMS could 
arise both from a placebo effect or due to the natural progression of depression which 
often includes symptom reduction even in the absence of treatment (Keller et al., 
1992). The evidence of long-term benefits of targeted AMS interventions is currently 
limited. 
 
Due to study characteristics it would be premature to interpret the overall results as a 
relative superiority of the treatments targeting memory. For general depression 
interventions, there was some evidence for effectiveness of MBCT, CBT and anti-
depressant medication on AMS, with CBT and anti-depressant use showing equivalent 
outcomes. It should be noted that only one of the other treatment studies excluded 
participants based on anti-depressant use (Gonçalves et al., 2009), which may have 
influenced the results in both the treatment and control groups through independent 
effects of medication on mood and cognition. Despite some evidence for LRT having 
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superiority over active control conditions, the equivalent outcomes of LRT and 
supportive therapy suggests that different types of psychological support, whether 
targeting AMS or not, may lead to similar outcomes (Serrano Selva et al., 2012).  
 
The studies included proposed a number of different pathways to the improvements in 
AMS, including direct effects on memory retrieval, changes in mood, or changes in 
cognitive processes targeted by interventions, such as rumination, flexibility and 
awareness (Maestas & Rude, 2012; Neshat-Doost et al., 2014; Williams et al., 2000). 
There is currently insufficient evidence for treatments targeting any particular factors, 
and further research is needed to distinguish between the effectiveness of different 
interventions and the active ingredients associated with change. In addition, 
interventions with different aims are likely to target a number of shared features, such 
as emotional regulation and memory processing (Lane, Ryan, Nadel & Greenberg, 
2015; Moyal, Cohen, Henik & Anhold, 2015). In light of the CaR-FA-X model and 
the bidirectional relationship between OGM and depressive symptoms, it is likely that 
change in AMS can be driven by several factors (Talarowska et al., 2016; Williams et 
al., 2007). The “dodo bird verdict” of psychological treatments, suggesting an 
equivalence of benefits and outcomes for mood across a number of different 
psychological interventions due to shared therapeutic features, may be applicable to 
the improvements in AMS as well as in depressive symptoms more generally (Hollon 
et al., 2002, Luborsky, 1995). Individual factors, such as the chronicity of depression 
symptoms, are likely to contribute to the effectiveness of interventions in improving 
AMS, but the studies included in the review did not allow for analysis or conclusions 
about this (Nandrino, Pezard, Posté, Réveillère & Beaune, 2002). Promisingly, there 
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was some evidence of improvement in OGM in chronic and recurrent depression 
(Hargus et al., 2010; Williams et al., 2000). 
 
The results from the prevention studies provided mixed and limited evidence of 
effectiveness. Whilst LRT produces benefits in AMS in non-depressed older adults, 
the other interventions targeting AMS lacked replication. One large study provided 
evidence that creative writing could lead to changes in AMS, but these results were 
only present at six-month follow-up (Maestas & Rude, 2012). The evidence for MBCT 
was mixed, with two studies suggesting a benefit whilst two studies did not replicate 
these findings, and concreteness training had no impact on AMS. The largest study in 
the review investigated the effect of CBT, MBCT and a reward processing programme 
for adolescents, with none of these showing a benefit on AMS compared to the control 
group (Rice et al., 2015). This lack of change in AMS in prevention studies may, 
however, be due to participants already having high levels of AMS. Previous reviews 
on prevention strategies for depression have similarly produced mixed results, and the 
use of immediate cognitive and symptom reduction measures in prevention studies can 
be problematic given the absence of dysfunction (Merry et al., 2009). The AMT may 
also have lower sensitivity for measuring AMS in non-clinical samples compared to 
individuals with depression (Griffith et al., 2009; Raes et al., 2007). 
 
4.1.2.! What are the links between improvement in AMS and depression symptoms? 
 
Overall, depression symptoms decreased in the treatment studies. As these included 
several uncontrolled trials, however, this result may partly be attributed to the natural 
progression of depression rather than the effectiveness of interventions (Keller et al., 
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1992). For the studies that reported statistical analysis of the association between 
change in AMS and change in depressive symptoms, the evidence was mixed. The 
conceptualization of OGM as both a risk factor and a consequence of depression 
suggests that the relationship between the variables may be complex and influenced 
by other factors, and a fuller understanding of the relationship may require subgroup 
analysis, inclusion of further cognitive measures, and larger sample sizes (Talarowska 
et al., 2016). The causal association between AMS and depression can also be 
interpreted in several ways. In some of the included studies, the authors argued that a 
lack of relationship between the two supports the effectiveness of interventions 
targeting memory, as the AMS improvement is not attributable to changes in mood 
(Williams et al., 2000). Others have interpreted an association as evidence of a causal 
relationship between AMS on depressive symptoms (Neshat-Doost et al., 2013). 
Overall, analyses of OGM controlled for changes in mood, suggesting that the changes 
in AMS were at least partially independent. In the small number of studies where 
mediation analyses were performed, the evidence of whether change in AMS mediates 
change in depression symptoms was conflicting. 
 
In the prevention studies, only two studies reported a change in depressive symptoms. 
Measuring symptom reduction in prevention studies and populations with sub-clinical 
levels of depression may not, however, provide a measure of clinically meaningful 
change due to low baseline scores (Merry et al., 2009).  
 
Across the prevention and treatment studies, only three trials reported statistical 
analysis of the relationship between change in AMS and other cognitive processes 
(Heeren et al., 2009; Maestas & Rude, 2012; Raes et al., 2009). Whilst these studies 
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reported correlations and partial mediation effects of measures of cognitive flexibility, 
avoidance, rumination and problem-solving, the limited amount of analyses and lack 
of replications does not allow for any conclusions to be drawn concerning the 
relationship between AMS and other cognitive processing. Distinction between these 
factors is likely to be complex due to their close relationship, and the likelihood of 
bidirectional and confounding associations, with OGM (Liu et al., 2017; Raes et al., 
2005; Raes et al., 2006).  
 
4.2.! Methodological limitations of the included studies 
 
The studies in this review included a number of methodological limitations. Firstly, 
none of the trials met the EPHPP criteria for RCTs (Thomas et al., 2004), which would 
provide the strongest evidence for effectiveness. Study methodologies of the CCTs 
could have been improved through reporting of randomisation procedures, double-
blinding and intention to treat analysis. Only five studies had an overall quality rating 
of strong. This, along with inclusion of uncontrolled trials, poses challenges to the 
attribution of change to the effectiveness of the interventions.  
 
Secondly, a number of limitations arise from the use of the AMT. The AMT is not a 
standardised scale, and different versions of this measure was used across studies. 
Whilst the relationship between OGM and depression is established across different 
versions of the AMT, it is possible that the variations in the demands of the tasks are 
associated with different outcomes (Liu et al., 2013). As a consequence of the 
variability between AMT versions, as well as interventions and populations, of studies, 
drawing conclusions about the possible relationship between features of the AMT and 
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outcomes was not possible. As this review addressed change within studies rather than 
the strength of the association, this is unlikely to have had a big impact on the results.  
A greater issue, however, is the potential influence of learning effects as a result of 
repeated administrating of the AMT, especially when the same cue words are used at 
different time points (Sumner et al., 2010). Only six studies in the review reported the 
use of different cue word at the different measurement times, but the pattern of results 
in these studies did not differ from the other trials.  
 
Thirdly, only one study included OGM in the inclusion criteria (Sabatelli, 2016). 
Interventions for individuals with high initial levels of AMS are unlikely to lead to 
statistically significant changes due to the limited scope for improvement.  
 
Fourthly, the included studies reported change in terms of statistical significance, 
which does not necessarily translate into clinical significance or benefit (Jacobson & 
Truax, 1991). Based on the studies included, it is possible to conclude that there was 
some improvement on performance on the AMT and other measures, but not whether 
this improvement had a further beneficial impact for individuals. Measurement 
methods of AMS that are more closely linked to an individual, such as diaries, self-
defining memory narratives, or the ReSSI used by Hargus and colleagues (2010), may 
provide more individually relevant information than the AMT (Sumner et al., 2013). 
The majority of studies also only reported change on depression measures in terms of 
statistical, but not clinical, significance.  
 
Finally, the generalisability of studies should be considered. For example, whilst 
evidence suggests that LRT increases AMS in older adults, it is unclear whether this 
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intervention would be effective in younger populations. The evidence in children and 
adolescents was limited, and the majority of participants were White European. The 
information in the studies did not allow for analysis or conclusions about sub-groups, 
including the effect of chronicity of depression on change in AMS. The quality of 
studies, along with heterogeneity between studies, meant that meta-analysis of results 
across studies was not possible. 
 
4.3.! Implications and future directions 
 
Despite the evidence that interventions, particularly for treating depression, can 
improve AMS, it was not possible to establish the relationship between these 
improvements and changes in depression symptoms. It was also not possible to 
establish whether any of the interventions were superior compared to others, or 
whether interventions targeting AMS were more effective in reducing OGM than 
general interventions. Further research is needed to build on the results from the 
uncontrolled trials. Encouragingly, two randomised trials for MeST and MemFlex, 
comparing the interventions to psychoeducation and support, are currently being 
conducted (Dalgleish et al., 2014; Hitchcock et al., 2015). For interventions targeting 
AMS, more research is needed to establish whether these interventions should be used 
as stand-alone therapies or in conjunction with existing treatments such as CBT. Given 
the mixed evidence from prevention studies, interventions should initially target 
people with current depressive symptoms. As the rationale for targeting AMS is to 
improve depression outcomes, there is a need for future research to address the links 
between change in AMS and changes in depression symptoms and outcomes. Future 
research should also target the relationship between change in AMS and rumination, 
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problem-solving and avoidance (Williams et al., 2007). If OGM is conceptualised as 
a risk factor for depression, measures of relapse or future depressive episodes may be 
more useful than symptom measures, in particular in prevention studies.  
 
Depression is a heterogeneous disorder in terms of both symptomology and cognitive 
profile. One of the challenges in treating and preventing depression is that no single 
treatment methods works for all, and little is currently known about factors that 
predicts treatment success. Interventions are often generic across individuals, although 
there may be an increased benefit of interventions that are individually tailored to the 
specific symptoms present, including problems with memory (Brewin et al., 2009). It 
may be, that some individuals would particularly benefit from interventions designed 
to improve AMS, whilst others may not. 
 
4.4.! Limitations of this review 
 
A number of limitations of this review should be acknowledged. Firstly, all steps of 
the systematic review was conducted by a single researcher, which introduces the risk 
of bias and inaccurate accounts. Secondly, despite a thorough search methodology, it 
is possible that some publications that would have provided important information 
were not identified. Thirdly, due to the heterogeneity and mixed results of the studies, 
it was not possible to draw conclusions about sub-groups of participants and 
interventions, or to further discuss the implications of the different measures of AMS 
that were used. 
 
4.5.! Concluding summary 
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There is promising evidence that clinical interventions for treating depression are 
followed by increases in AMS, but there is no clear evidence for superiority of any 
particular intervention, or for the association with change in depressive symptoms. The 
evidence for preventative strategies improving AMS is limited. Further research is 
needed to establish the effectiveness of interventions in improving AMS and their 
clinical benefits. 
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Abstract 
 
Aims: Depression is associated with deficits in autobiographical memory (AM) 
specificity. As the hippocampus underlies AM recall, and is associated with atrophy 
in depression, it provides an area of interest for understanding the neural correlates of 
memory deficits in depression. The aim of this study was to investigate the association 
between AM and allocentric spatial memory as a measure of hippocampal function in 
depression.  
 
Method: 34 adults with chronic or recurrent symptoms of depression, and 35 adults 
without depression, completed the Autobiographical Memory Test (AMT) and the 
Four Mountains Test (4MT) as a measure of allocentric spatial memory, along with a 
number of clinical symptom measures.  
 
Results: There was no association between performance on the AMT and the 4MT. 
The depression group had lower scores on the AMT than the comparison group, but 
there was no difference between 4MT scores. Performance on the memory tasks was 
not associated with chronicity or severity of depressive symptoms.  
 
Conclusions: Findings of AM deficits in depression were replicated. No deficits in 
hippocampus-dependent spatial memory, or evidence of an association between AM 
performance and hippocampal function measured by spatial memory, were found. 
Further research is needed to understand the neurological correlates of AM deficits in 
depression.   
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1.! Introduction 
 
1.1.! Depression, memory and the hippocampus 
 
Depression is a common mental health problem, with estimates suggesting a global 
prevalence of 4.4% (World Health Organisation, 2017). Whilst a range of evidence-
based interventions are available, current treatments do not benefit everybody, and 
relapse rates are high (Burcusa & Iacono, 2007; Cuijpers et al., 2014; De Maat, 
Dekker, Schoevers & De Jonghe, 2006; Malhi et al., 2015). The suffering and costs 
associated with depression, along with the limitations of existing treatments, highlights 
the importance of increasing the understanding of the aetiology and features of 
depression.  
 
Diagnostic criteria for depression are based on the emotional features of the disorder, 
with the core symptoms including depressed mood and loss of interest and pleasure 
(American Psychiatric Association, 2013). In addition, depression is associated with a 
range of cognitive and executive symptoms, including effects on memory, which 
contribute to the disability burden (Dalgleish & Werner-Seidler, 2014; Darcet, 
Gardier, Gaillard, David & Guilloux, 2016; Gonda et al., 2015; Köhler et al., 2015; 
Rock, Roiser, Riedel & Blackwell, 2014; Snyder, 2013). There has been increased 
interest in linking the deficits in memory with the neurological features of depression, 
and improved understanding of the interaction between cognitive and biological 
factors may contribute to the improvement of treatment strategies (Rock et al., 2014).  
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Neuroimaging studies have demonstrated differences between healthy controls and 
individuals with depression in a range of cortical regions, including areas associated 
with emotional regulation and reward seeking (Kupfer, Frank & Phillips, 2012; Liu et 
al., 2017). One of the most widely studied brain regions in depression is the 
hippocampus (Liu et al., 2017). As the notable functions of the hippocampus include 
episodic and spatial memory, it provides an area of interest for understanding memory 
deficits in depression (Campbell & MacQueen, 2004; Eichenbaum & Cohen, 2014; 
Schiller et al., 2015). Bilateral structural and functional differences, including 
reductions in volume, have consistently been found in the hippocampus and 
surrounding structures in depression, particularly when symptoms are chronic and 
recurrent (Campbell & MacQueen, 2004; Chan et al., 2016; Finkelmeyer et al., 2016; 
Kaymak et al., 2010; McKinnon, Yucel, Nazarov & MacQueen, 2009; Schmaal et al., 
2016). Changes in the hippocampal structure are also found in individuals with post-
traumatic stress disorder (PTSD) (Smith, 2005). Exposure to periods of stress is 
associated with neurotoxic levels of cortisol and dysregulation of the hypothalamic 
pituitary adrenal (HPA) axis, leading to alterations in hippocampal development and 
function, and offering an explanation for the hippocampal deficits in emotional 
disorders (Frodl & O’Keane, 2013; Heim, Newport, Mletzko, Miller & Nemeroff, 
2008; McEwen, 2005; Stein, Koverola, Hanna, Torchia & McClarty, 1997; 
Talarowska, Berk, Maes & Galecki, 2016; Wilkinson & Goodyer, 2011).  
 
Despite compelling evidence linking depression with hippocampal alterations, the 
associated behavioural changes are not well understood (Fairhall, Sharma, Magnusson 
& Murphy, 2010). This study investigated the well-established impairments in 
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autobiographical memory in depression with the potential association with allocentric 
spatial memory as an indicator of hippocampal functioning. 
 
1.2.! Overgeneral autobiographical memory in depression 
 
A robust evidence base suggests that impairment in autobiographical memory (AM) 
recall is a feature of depression (Liu, Li, Xiao, Yang & Jiang, 2013; Ono, Devilly & 
Shum, 2016; Williams et al., 2007). AM is the memory function that allows humans 
to recall past experiences and relive past events in the present (Tulving, 2002). It is 
part of the human declarative memory system, but distinct from semantic memory as 
it relies on access to specific contexts and spatio-temporal information about events 
(Moscovitch, Cabeza, Wincour & Nadel, 2016). Access to AM provides a basis for 
social interaction, problem solving, decision making, and sense of identity, and 
accordingly deficits can lead to profound impacts on functioning and well-being 
(Talarowska et al., 2016; Tulving, 2002).  
 
The impairment of AM in depression, also referred to as overgeneral memory (OGM), 
was first described by Williams and Broadbent (1986) who compared the ability to 
retrieve specific autobiographical memories (defined as personally experienced events 
that lasted less than a day) between suicide attempters and controls using the 
Autobiographical Memory Test (AMT). In the AMT, participants are presented with 
cue words (e.g. happy), and asked to recall a memory of a specific event that the word 
reminds them of (e.g. the day my daughter was born). Suicidal patients were less likely 
to recall specific events and more likely to recall categorical events and longer time-
periods of their life (e.g. when my daughter was a baby). Overgenerality appears to be 
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specific to AM, with deficits in specificity not being found in semantic memory tasks, 
and OGM being present when other aspects of cognition are controlled for (Söderlund 
et al., 2014; Williams & Broadbent, 1986; Williams et al., 2007). 
 
Subsequently, a large number of studies across different settings have replicated OGM 
as a feature of depressive disorders (Liu et al., 2013; Sumner, 2012; Williams et al., 
2007). OGM is also associated with remitted and sub-clinical depression, and is 
predictive of future episodes and relapse (Sumner, Griffith & Mineka, 2010). OGM 
may contribute to the maintenance of depression by interfering with problem-solving 
and enhancing rumination (Sumner et al., 2010). However, there is seemingly no 
correlation between symptom severity and OGM, and the links with length of illness 
are unclear (Gibbs & Rude, 2004; King et al., 2010; Wessel, Meeren, Peeters, Arntz 
& Merckelbach, 2001; Williams et al., 2007). 
 
Explanatory models of OGM have focused on the cognitive processes that can interfere 
with AM retrieval. Early models proposed that OGM, which is also found in PTSD, 
could be explained by a single main factor such as trauma and subsequent avoidance 
of specific memories (Moore & Zoellner, 2007; Valentino, 2011). More recent models 
recognise a number of factors that contribute to OGM, including rumination and 
deficits in executive function (Sumner, 2012; Williams et al. 2007). The neural 
underpinnings and correlates of AM may offer a novel avenue for understanding OGM 
(Piolino, Desgranges & Eustache, 2009; Valentino, 2011). The hippocampus, being 
one of the key brain structures involved in AM, and associated with depression and 
trauma, offers an area of interest when considering the neurology of AM deficits in 
depression (Campbell & MacQueen, 2004; Conway, 2005; Talarowska et al., 2016). 
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1.3.! Autobiographical memory and the hippocampus 
 
Early evidence for hippocampal involvement in AM was demonstrated by lesion 
studies where hippocampal damage was associated with the loss of AM, whilst other 
forms of declarative memory remained intact (Bird & Burgess, 2008; Eichenbaum, 
2004; Eichenbaum & Cohen, 2014; Eichenbaum, Sauvage, Fortin, Komorowski & 
Lipton, 2012). Extensive neuroimaging data has since further supported the 
hippocampal role in AM (Greenberg & Rubin, 2003; Martinelli, Sperduti & Piolino, 
2013; Moscovitch et al., 2005; Piolino et al., 2009; Svoboda, McKinnon & Levine, 
2006). The hippocampus appears to have a selective role in AM compared to other 
forms of declarative memory, such as semantic information, possibly through 
providing and incorporating a range of contextual information (Eichenbaum et al., 
2012; Holland, Addis & Kensinger, 2011; Martinelli et al., 2013; Moscovitch et al., 
2005). Whilst early models of AM suggested that hippocampal involvement decreased 
with the time passed since formation of a memory, current evidence suggests 
continuous hippocampal involvement regardless of memory age (Cabeza & St Jaques, 
2007; Moscovitch et al., 2005; Piolino et al., 2009). The hippocampus is not a uniform 
structure, and evidence suggests that different subfields may be associated with 
different aspects of AM, such as encoding, consolidation, and clarity of memories 
(Chadwick, Bonnici & Maguire, 2014; Mueller, Chao, Berman & Weiner, 2011). The 
Cornu Ammonis region 3 (CA3) of the hippocampus appears to be particularly 
important for AM, and there is also evidence of the left hippocampus playing a larger 
role in AM than the right hippocampus (Chadwick et al., 2014; Martinelli et al., 2013).  
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A smaller number of studies have investigated the link between OGM, depression and 
the hippocampus. Associations have been found between lower grey matter volume in 
the hippocampus and OGM (Young, Bellgowan, Bodurka & Drevets, 2015a). 
Differences in blood-oxygen-level dependent (BOLD) responses in functional 
magnetic resonance imaging (fMRI) between depressed individuals and controls 
performing AM tasks have also been identified in regions including the prefrontal 
cortex, the amygdala, occipital regions and the hippocampus (Whalley, Rugg & 
Brewin, 2012; Young et al., 2012; 2016; Young, Bellgowan, Bodurka & Drevets, 
2013). One study found decreased hippocampal activation during AM retrieval in 
depressed individuals, but the difference between groups was not evident when 
specific memories were retrieved (Young et al., 2012). Two studies have found 
increased BOLD activity in the left hippocampus in individuals with depression or 
high risk for depression during recall of specific memories (Young, Bellgowan, 
Bodurka & Drevets, 2014; Young et al., 2016). The authors interpreted this as 
reflecting increased hippocampal activity to compensate for atrophy in this region. 
Other studies have reported no significant differences in hippocampal activation 
between depressed and non-depressed individuals during AM tasks (Hach, Tippett & 
Addis, 2014; Young et al., 2013; Young, Bellgowan, Bodurka & Drevets, 2015b). 
 
1.4.! Hippocampus-dependent spatial memory 
 
Another key function of the hippocampus is its involvement in spatial navigation and 
memory (Bird & Burgess, 2008). Spatial memory depends on multiple parallel 
memory systems, including allocentric (view-point independent) and egocentric 
(observer/view-point dependent) spatial memory (Burgess, 2008). Allocentric spatial 
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memory (ASM) stores representations that are not bound to a specific view-point or 
perspective, and hence underlies recognition of locations from new perspectives, 
recollection of environmental topography, and flexible navigation (Hartley et al., 
2007).  
 
The hippocampus is involved in long-term egocentric spatial memory, but short-term 
egocentric spatial memory largely depends on different cortical regions (Moscovitch 
et al., 2005; Weniger, Ruhleder, Wolf, Lange & Irle, 2009). For ASM, however, the 
hippocampus is the crucial cortical structure for both long-term and short-term 
recollections (Burgess, Maguire & O’Keefe, 2002; Byrne, Becker & Burgess, 2007; 
Holdstock et al., 2000; King, Burgess, Hartley, Vargha-Khadem & O’Keefe, 2002; 
Yee, Hannula, Tranel & Cohen, 2014). Early literature on spatial memory and the 
hippocampus came from animal studies, including the identification of the 
hippocampus creating a cognitive map of the environment through the firing of “place 
cells” that respond to different features of the external surroundings (O’Keefe & 
Nadel, 1978). Place cells, that have subsequently also been identified in humans, 
respond to topographic features of the environment regardless of egocentric properties 
(Doeller, Barry & Burgess, 2012; Ekström et al, 2003). Functional imaging has further 
shown that the hippocampus is a key structure in ASM in humans, and distinguished 
its neural underpinnings from those of semantic memory and general cognitive 
functioning (Ekström et al., 2003; Hartley & Harlow, 2012; Hartley, Lever, Burgess 
& O’Keefe, 2014; Hartley, Maguire, Spiers & Burgess, 2003; Spiers, Maguire & 
Burgess, 2001).  
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Due to its specialised role in ASM, a number of virtual reality and topographical spatial 
memory tasks have been developed to reflect hippocampal functioning (Burgess et al., 
2002; Hartley et al., 2007; King et al., 2002). Hartley and colleagues developed the 
computer-based Four Mountains Test (4MT), where spatial memory is measured using 
a virtual landscape that is manipulated to vary on features dependent on allocentric 
and non-spatial memory. Their findings suggest that individuals with hippocampal 
damage show specific impairments in the allocentric condition, along with unaffected 
memory performance in the non-spatial condition. The 4MT has also been used with 
individuals with mild cognitive impairment and Alzheimer’s Disease, in which 
hippocampal atrophy is an early factor, and has shown sensitivity in identifying, 
predicting and distinguishing Alzheimer’s disease from other dementias (Bird, Chan, 
Hartley, Pijnenburg, Rossor & Burgess, 2010; Chan et al., 2016; Guderian et al., 2015; 
Moodley et al., 2015; Pengas et al., 2012; Wood, Moodley, Lever, Minati & Chan, 
2016). In healthy adults, performance on the test is associated with hippocampal 
volume (Hartley & Harlow, 2012). Together, these findings suggest that performance 
on the 4MT can offer an indication of hippocampal function.  
 
Compared to the literature on OGM, less is known about the relationship between 
depression and spatial memory. Emerging evidence from studies using virtual reality 
tasks suggests that ASM may be impaired in depression, but this has not been 
consistently found across tasks (Cornwell et al., 2010; Gould et al., 2007; Wong, 
2015). A study comparing individuals with PTSD with trauma-exposed controls, 
showed that PTSD was associated with a selective impairment in ASM, whilst 
egocentric and non-spatial memory was intact (Smith, Burgess, Brewin & King, 2015). 
Animal studies suggest that repeated exposure to stress causes impairment on spatial 
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memory tests, which is possibly linked with the effect of cortisol and the HPA-axis on 
the hippocampus (Conrad, 2010; Darcet et al., 2016). Depression, or negative life 
events, may similarly interfere with human spatial memory through the effect of stress 
responses on the hippocampus.  
 
Whilst there is some evidence for functional specialisation of the hippocampus, such 
as the left hippocampus showing specialisation in AM and the right hippocampus in 
ASM, and the anterior hippocampus showing relatively higher involvement in the 
construction of conceptual representation whilst the posterior hippocampus is 
responsible for perceptual representations, there appears to be significant overlap 
between the neural underpinnings of the two types of memory (Burgess et al., 2002; 
Martinelli et al., 2013; Piolino et al., 2004; Sheldon & Levine, 2016). A number of 
theories have been proposed to explain the relationship and shared neural structures of 
AM and ASM, including AM depending on allocentric processing for the 
contextualising of and distinguishing between spatial and temporal information (Bird 
& Burgess, 2008; Burgess et al., 2002). Others suggest that the link between episodic 
and spatial memory in the hippocampus is best explained through conceptualising the 
function of the hippocampus as a cognitive map that can organise and bind information 
across a number of domains (Eichenbaum, 2015; Olsen, Moses, Riggs & Ryan, 2012; 
Schiller et al., 2015). Despite the shared dependence on the hippocampus, there is a 
lack of behavioural research linking AM and ASM (Moscovitch et al., 2005). Based 
on current evidence, however, it is plausible that impaired hippocampal function and 
ASM could contribute to impairments in accessing specific memories in depression. 
 
1.5.! Rationale and aim of the study 
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Improved understanding of the behavioural and neuropsychological correlates and 
processes involved in depression can contribute to the development of more effective 
treatments. The aim of this study was to unite some of the separate strands of research 
on correlates of depression to increase the understanding of AM deficits and the role 
of the hippocampus in depression. There is robust evidence for deficits in AM in 
depression and for the hippocampal involvement in AM and ASM. Whilst the effects 
of depression on ASM are less well understood, it is possible that impairments are 
present. To date, no studies known to the author have investigated the relationship 
between AM and ASM deficits in depression. This study aims to investigate the link 
between AM specificity and ASM as an index of hippocampus function in individuals 
with and without depression. 
 
1.6.! Hypotheses 
 
Primary hypothesis: There will be an association between AM specificity and 
hippocampus-dependent ASM in depressed and non-depressed adults.  
 
Hypothesis two: The depression group will show impairment in AM specificity 
compared to the non-depressed comparison group.  
 
Hypothesis three: The depression group will show impairment in ASM compared to 
the non-depressed comparison group. 
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Hypothesis four: Earlier onset and chronicity of depression will be associated with 
increased impairments in AM and ASM. 
 
2.! Method 
 
2.1.! Joint project arrangement 
 
The data for this study was collected as part of a joint project with a fellow trainee 
clinical psychologist (Williams, 2017). The research questions for the two projects 
were based on separate measures of memory. As the measures used for the other 
project were unlikely have an impact on the results, and were not used for analysis, 
only measures relevant to this project will be described. Further details about the joint 
project arrangement are presented in Appendix A and B. 
 
2.2.! Design 
 
The study had a cross-sectional correlational design, with the primary hypothesis 
investigating the association between AM specificity and performance on a 
hippocampus-dependent ASM task across depressed and non-depressed adults. 
 
2.3.! Setting 
 
Individuals with depression were recruited from current service users of Improving 
Access to Psychological Therapies (IAPT) services within a National Health Service 
(NHS) mental health trust. Participants without depression were recruited through two 
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online research participation websites (uclpsychology.sona-systems.com and 
callforparticipants.com).  
 
2.4.! Ethical approval and reimbursement 
 
Ethical approval for this study was provided by the National Research Ethics Service 
Committee East Midlands – Nottingham 2 (Reference: 14/EM/0222) and by the 
University College London Clinical, Education and Health Psychology (CEHP) 
Programme Ethical Approval (Reference: SHaPS-2014-JK-009) (Appendix C and D).  
 
All participants received a copy of the participant information sheet by email prior to 
their participation. Before testing, the researchers ensured that the participants had 
understood this information, and participants signed a consent form (Appendix E and 
F).  
 
Participants received £12.50 in reimbursement for study participation. In the 
comparison group, five participants received course credit instead of the cash payment. 
 
2.5.! Participants 
 
2.5.1.! Sample size 
 
The sample size calculation for the study was conducted using G*Power (version 3.1) 
(Faul, Erdfelder, Buchner & Lang, 2009). As no previous literature on AM and 
hippocampus dependent ASM was available, estimation of the effect size relied on 
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related literature. Williams and colleagues (2007) examined 28 studies looking at 
depressive disorders and OGM, and found the mean effect size to be large (d=0.94). 
Wong (2015) found a large effect size in ASM performance between individuals with 
and without depression (d=0.83), but this effect was not found across different tests of 
allocentric memory. A study investigating ASM in individuals with and without PTSD 
found a medium effect size between memory impairment and diagnosis (ηp2=0.10) 
(Smith et al., 2015). Based on these results, the effect size estimate was set at medium 
to maximize the chances of identifying an existing effect within the practical scope of 
this project. 
 
The calculation for linear multiple regression with one dependent (AM specificity) and 
two independent variables (depression status and ASM performance), alpha level of 
0.05 and power of 0.80 indicated a sample size of 68 to detect a medium effect size 
(f2=0.15). Due to the joint project’s sample size calculation relying on comparison 
between the depression and the comparison group, this sample was split into two 
groups. The target sample was reached, with 34 participants in the depression group 
and 35 participants in the comparison group. 
 
2.5.2.! Inclusion and exclusion criteria 
 
Right-handed, English-speaking adults aged between 18 and 65 were eligible to take 
part in the study. The exclusion criteria included features that may influence memory 
performance independently from depression. A subset of the screening questions from 
the Structured Clinical Interview for DSM Axis I Disorders (SCID-I; First, Spitzer, 
Gibbon & Williams, 1996) were used to screen for exclusion criteria of current 
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psychiatric disorders other than depression. Self-report questions were used to screen 
for depression history, past diagnosis of PTSD or psychosis, history of a head injury, 
current use of tranquilisers, current substance misuse, a diagnosed learning disability, 
or visual impairment that would interfere with ability to use a computer.  
 
For the clinical group, inclusion criteria further included a current score of ten or above 
(indicating at least moderate symptoms of depression over the last two weeks) on the  
Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001). The PHQ-
9 question about suicidality was not used during the screening process, and the 
inclusion score was calculated on the basis of eight rather than the standard nine 
questions. Based on evidence of hippocampal changes in depression being associated 
with chronicity and severity of symptoms, further inclusion criteria included a history 
of long-term or recurrent depression (first episode more than 2.5 years ago; or current 
episode lasting over 2.5 years) (Schmaal et al., 2016). Given the high co-morbidity 
between depression and anxiety, participants in the depression group were not 
excluded based on symptoms of generalized anxiety or panic disorder (Spitzer, 
Kroenke, Williams & Lowe, 2006).  
 
For the comparison group, inclusion criteria included a score of five or less on the 
PHQ-9 and the Generalised Anxiety Disorder Scale (GAD-7; Spitzer et al., 2006), and 
no more than one historic episode of depression. 
 
2.5.3.! Recruitment 
 
– 91 – 
The depression group was recruited through the IAPT services in a NHS mental health 
trust. Participants were recruited for the study through two different routes: 
 
1)! Participants were given information about the study by their therapist. If a 
service-user was interested in taking part and consented to being contacted 
by the researchers, the therapist gave their contact details to the 
researchers. 
 
2)! The IAPT services keep a record of current service-users who have 
consented to being contacted about research participation. This record also 
includes some clinical information, such as PHQ-9 scores. Service-users 
who had consented to being contacted and whose last recorded PHQ-9 
score was ten or above were emailed information about the study. If no 
response was received for at least a week, follow-up phone calls were 
attempted to enquire about interest in the study. 
 
Participants for the comparison group were recruited through adverts on two research 
participation websites.  
 
For all participants who expressed an interest in taking part in the study, a screening 
phone call was arranged to assess eligibility. For participants who were eligible, a 
testing slot was arranged at one of the clinical sites of the IAPT services (depression 
group) or at University College London (comparison group). 
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The recruitment sources and number of participants at each stage are presented in 
Table 1.  
 
Table 1. Number of participants at each stage of recruitment 
Number of participants at each stage of recruitment 
 Depression group Comparison group 
Recruitment source Current service-users of 
Improving Access to 
Psychological 
Therapies Service 
General public 
Recruitment method Emails/phone calls to 
individuals having 
consented to contact 
about research 
participation 
Research recruitment 
websites available to 
the general public 
(uclpsychology.sona-
systems.com and 
callforparticipants.com) 
Number contacted (N) 282 – 
Number screened (N) 60 39 
Screened but not eligible (N) 21 2 
Completed testing (N) 36 35 
Included in analysis (N) 34 35 
Total Sample (N) 69 
 
2.6.! Measurement tools and data collection 
 
2.6.1.! Measurement tools 
 
Demographic information was collected through a self-report questionnaire, which 
included questions on age, gender, ethnicity, educational history, occupation, 
household income and first language (English or not).  
 
The Beck Depression Inventory II (BDI-II; Beck, Steer & Brown, 1996) (clinical 
group only) was used to assess current depression symptoms for the clinical group. 
The BDI-II was developed as a screening tool to assess symptoms of depression based 
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on the criteria for depressive disorders in the Diagnostic and Statistical Manual IV 
(American Psychiatric Association, 2000), and is a widely used tool in clinical 
research. The BDI-II is a 21-item self-report questionnaire, assessing symptoms of 
depression during the past two weeks. Each item has four response options, ranging 
from not present (0) to severe (3). Respondents receive an overall score between 0 and 
63. Review of the BDI-II has shown good validity, sensitivity and specificity for 
detection of depression compared to diagnostic criteria, an internal consistency of 
around α=0.9 and test-retest reliability of r=0.73-0.96 (Wang & Gorenstein, 2013).  
 
The Generalised Anxiety Disorder Scale 7 (GAD-7; Spitzer et al., 2006) (clinical 
group only) was used to assess current anxiety symptoms in the clinical group. The 
GAD-7 is a seven-item self-report measure for symptoms of generalized anxiety 
disorder over the past two weeks. For each item, respondents are asked to rate the 
frequency of symptoms using four response options ranging from not at all (0) to 
nearly every day (3). Respondents receive an overall score between 0 and 21. In 
psychiatric populations, the GAD-7 has shown good internal consistency and good 
validity when compared to other measures of worry, anxiety and stress (Kertz, Bigda-
Peyton & Bjorgvinsson, 2013; Spitzer et al., 2006). 
 
Depression history (clinical group only) was assessed through a structured interview, 
including the date of the start of the initial and current episodes, number of past 
episodes, and details of treatment history. If participants were unsure about an answer, 
they were asked to provide an estimate.  
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The Autobiographical Memory Test (AMT; Williams & Broadbent, 1986) was used 
to assess autobiographical memory specificity. The cue words from the original AMT 
were used, and included five positive (happy, safe, interested, successful, surprised) 
and five negative (sorry, angry, clumsy, hurt, lonely) words. Participants were told to 
think of and describe a specific memory for each cue word. It was explained that a 
specific memory refers to an event that they have experienced, that occurred at a 
particular time and place, and lasted less than 24 hours. Participants were told that the 
memory could have occurred recently or a long time ago, that it could be an important 
or trivial event, and to think of a different memory for each cue word. Before starting 
the task participants were given an example of a specific (Jane’s party last Friday) 
and a non-specific memory (I enjoyed going to parties), and completed two practice 
trials (relieved, tired) verbally without a time limitation to ensure they had understood 
the instructions. The cue words were presented verbally and in written form in a 
booklet with one cue word per page. Participants had to provide a verbal response 
within 30 seconds, which they then wrote down in the booklet provided. If their verbal 
response within 30 seconds was not specific, they were prompted one time (Can you 
think of a specific event?). If participants could not think of a memory within 30 
seconds, they were asked to move on to the next cue word.  
 
Participant responses were coded by a trainee clinical psychologist who was blind to 
the clinical status of participants and to the hypotheses of the study. Memories were 
coded as specific (events that happened once and took place over a day or less), 
categorical (recurrent events), extended (events that lasted longer than a day), 
omissions (no memory recalled within time limit), or as non-memories (e.g. statements 
about current feelings). The primary researcher additionally coded the results of 20 
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participants (200 items), to calculate the inter-rater reliability, which was 90% (κ=.81). 
This is similar to previous studies, and suggests good inter-rater reliability (Griffith et 
al., 2012). The total number of specific memories were calculated for each participant 
with the maximum possible score being ten. Whilst the AMT is the standard tool for 
assessing AM specificity, it is a testing paradigm rather than a standardized measure, 
(Liu et al., 2013). It has, however, proved to be feasible and reliable across a large 
range of settings, and has demonstrated validity through its relationship with other 
features of depression (Griffith et al., 2009; 2012; Williams et al, 2007).  
 
The Four Mountains Test (4MT, Hartley et al., 2007) was used to measure 
hippocampus-dependent allocentric topographical memory. The study used the revised 
version of the original task that includes 30 topographical memory items, without any 
trials that can be solved using non-spatial memory (Hartley & Harlow, 2012). The 
4MT was presented to participants using Microsoft Office PowerPoint software on a 
15-inch laptop. 
 
The 4MT measures participants’ ability to recognize topographical scenes of 
landscapes from different viewpoints (Figure 1). Participants are presented with the 
target landscape, including four mountains of differing sizes, shapes and topographical 
relations, for ten seconds. They are then asked to identify the target landscape from a 
new viewpoint from four choices that are presented simultaneously for 20 seconds. 
Non-spatial aspects of the scenes (e.g. colour, shadows, light) are manipulated, so that 
memory relies only on topographical aspects of the landscape.  
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Before starting the task, participants were given verbal instructions, and completed 
four practice trials for which they received performance feedback. Participants 
recorded their answers for each item on a record sheet. The total score for the 4MT 
was calculated based on the number of correct responses (maximum score: 30), with a 
chance score of 7.5 (Hartley & Harlow, 2012). 
 
As the 4MT has been used in experimental studies across different populations, its 
formal psychometric properties are not yet established. However, it has been used as 
a feasible measurement tool across populations with neurological injury, cognitive 
impairment, depression and healthy controls, and has demonstrated sensitivity to 
hippocampal impairment and function across populations with brain injury and 
cognitive impairment (Bird et al., 2010; Chan et al., 2016; Guderian et al., 2015; 
Moodley et al., 2015; Pengas et al., 2012; Wood et al., 2016). 
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Figure 1. Example of trial and correct response from the 4MT 
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2.6.2.! Procedure 
 
Participants attended the testing session at either one of the IAPT clinics (depression 
group) or at University College London (comparison group). The researchers went 
through the participant information form (which had been provided to participants by 
email prior to the session), and the participants signed the consent form. Participants 
then filled in the questionnaires, after which the clinical group completed the 
depression history interview. Participants then completed the AMT, followed by the 
4MT. A third memory task that was not used in the analysis of this study was then 
completed. The total testing time was approximately 75 minutes. At the end of the 
testing session, participants were given the opportunity for a debrief. 
 
2.7.! Data analysis 
 
The data analysis was performed using the Statistical Package for Social Sciences 
(SPSS) version 22. The distributions of all variables were explored to ensure normality 
assumptions were met, and potential differences on demographic variables between 
the groups were explored. The primary hypothesis was tested using multiple linear 
regression. Differences in memory performance between groups were explored using 
t-tests. For the clinical group, the relationship between memory performance and 
clinical variables were explored using correlational analysis. 
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3.! Results 
3.1.! Data preparation 
 
3.1.1.! Missing data 
 
One participant was excluded from analysis due to not completing the 4MT (reported 
finding this task too difficult). There was no further missing data for the AMT and the 
4MT. The number of past episodes of depression was missing for five participants. 
They were excluded from the correlational analysis on number of past depressive 
episodes. 
 
3.1.2.! Outliers 
 
The presence of potential outliers was examined through inspection of histograms, box 
plots and z-scores using a threshold of z<3. No outliers were identified for the AMT 
and 4MT scores. One outlier was identified for number of past depressive episodes, 
and was excluded in the correlational analysis of that variable. 
 
3.1.3.! Normality checks 
 
The distributions of scores of the variables included in the statistical analysis were 
examined through calculating z-scores for kurtosis and skewness, and the 
Kolmogorov-Smirnov statistic. The scores on the AMT and the 4MT met the 
assumptions for parametric testing. The clinical variables (BDI-II scores, GAD-7 
scores, time since onset, number of past episodes and time since first episode) were 
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not normally distributed, and statistical methods not assuming normality were used for 
analysis of these. 
 
3.2.! Descriptive statistics 
 
3.2.1.! Demographics 
 
36 participants in the depression group and 35 participants in the comparison group 
completed testing. In the depression group, one participant was left-handed (part of 
exclusion criteria) and another participant did not complete the 4MT. These 
participants were excluded from the analysis, leaving 34 participants in the depression 
group and a total sample of 69 participants.  
 
Demographic data for participants are presented in Table 2. The age range across the 
two groups was 18 to 62 with a mean age of 32.96 (SD=12.10). The sample was 56.5% 
female, and 71% had English as their first language. Overall, the sample was highly 
educated, with 72% of participants having a university degree. As these variables could 
have had an impact on memory performance, potential differences between the groups 
were explored. There were no statistically significant difference between the 
depression and the comparison group for age (t(67)=-.904, p=.369), gender 
(X2(1)=1.16, p=.281), English as first language (X2(2)=2.30, p=.130) or educational 
background (X2(5)=3.102, p=.684). 
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Table 2. Participant demographics 
Participant demographics 
 Clinical group 
(N=34) 
Comparison 
group (N=35) 
Total 
(N=69) 
Age M(SD) 34.29 (12.81) 31.66 (11.40) 32.96 (12.10) 
Gender N(%)    
Female 17 (50) 22 (62.9) 39 (56.5) 
Male 17 (50) 13 (37.1) 30 (43.5) 
English as first 
language N(%) 
   
First language 27 (79.4) 22 (62.9) 49 (71) 
Not first language 7 (20.6) 13 (37.1) 20 (29) 
Ethnicity N(%)    
White British 18 (52.9) 6 (17.1) 24 (34.8) 
White Other 8 (23.5) 8 (22.9) 16 (23.2) 
Mixed 2 (5.9) 3 (8.6) 5 (7.2) 
Asian 6 (17.6) 12 (34.3) 18 (26) 
Black   5 (14.3) 5 (7.2) 
Other  1 (2.9) 1 (2.9) 
Education N(%)    
Secondary or less 3 (8.8) 2 (5.7) 5 (7.2) 
Post-secondary 5 (14.7) 5 (14.3) 10 (14.5) 
Vocational 2 (5.9) 2 (5.7) 4 (5.8) 
Undergraduate 13 (28.2) 11 (31.4) 24 (34.8) 
Postgraduate 11 (32.4) 15 (42.9) 26 (37.7) 
Income N(%)    
Less than £15.000 10 (29.4) 9 (25.7) 19 (26.8) 
£15.000-£25.000 4 (11.8) 7 (20) 11 (15.5) 
£26.000-£35.000 4 (11.8) 8 (22.9) 13 (18.3) 
£35.000-£50.000 6 (17.6) 9 (25.7) 16 (22.5) 
£50.000-£70.000 3 (8.8)  2 (4.2) 
£70.000 or more 5 (14.7) 2 (5.7) 7 (9.9) 
 
3.2.2.! Clinical symptoms and depression history 
 
The clinical data and depression history of participants in the depression group are 
presented in Table 3.  
 
The BDI-II scores ranged from 11 to 48, with the mean being 29.00 (SD=8.05). Using 
the standard categories for the BDI-II, 5.9% of scores were in the category for mild 
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depression, 44.1% for moderate depression and 50% for severe depression (Beck et 
al., 1996). The mean number of previous episodes was 2.97 (SD=1.43). The mean 
length of the current episode was 25.12 months (SD=37.56), and the mean number of 
months since initial onset was 204 (SD=147.43), or around 17 years. Fifty-three 
percent of participants were currently taking anti-depressant medication, and 70% 
reported having a first-degree relative who had also suffered from depression. 
 
Table 3. Depression characteristics in clinical group 
Depression characteristics in depression group 
BDI-II score M(SD) 29 (8.05)  
BDI-II category N(%)  
Mild depression 2 (5.9) 
Moderate depression 15 (44.1) 
Severe depression 17 (50.0) 
GAD-7 score M(SD) 11.24 (3.49)  
GAD-7 category N(%)  
Minimal 1 (2.9) 
Mild 11 (32.4) 
Moderate 17 (50.0) 
Severe 5 (14.7) 
Length of episode (months) M(SD) 25.12 (37.56)  
Number of past episodes M(SD)* 2.97 (1.43) 
Time since first episode (months) M(SD) 204.35 (147.43)  
Anti-depressant medication N(%) 18 (53) 
Family history N(%) 23 (70) 
*Data missing for five participants 
The GAD-7 scores ranged from 4 to 21, with the mean being 11.24 (SD=3.49). Only 
one participant showed minimal symptoms of anxiety, whilst 32.4% fell in the 
category for mild symptoms, 50% for moderate symptoms and 14.7% for severe 
symptoms (Spitzer et al., 2006).  
 
3.2.3.! Memory performance  
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The scores for the AMT and 4MT are presented Table 4. The mean number of specific 
memories on the AMT was 6.85 (SD=1.88) in the depression group and 8.29 
(SD=1.53) in the comparison group. The mean score on the 4MT was 21.18 (SD=3.82) 
in the depression group and 20.26 (SD=4.13) in the comparison group. None of the 
participants scored below chance level on the 4MT. 
 
Table 4. Mean scores and significance testing for the Autobiographical Memory Test (AMT) and the Four Mountains Test (4MT 
 
Mean scores and significance testing for the Autobiographical Memory Test (AMT) 
and the Four Mountains Test (4MT) 
 Depression 
group  
(N=34) 
Comparison 
group (N=35) 
t p value 
AMT M(SD)     
Specific 
memories 
6.85 (1.88) 8.29 (1.53) 3.48 .01 
Positive specific 
memories 
3.62 (1.26) 4.42 (0.78) 3.24 .002 
Negative specific 
memories 
3.23 (1.04) 3.86 (1.06) 2.45 .017 
4MT M(SD) 21.18 (3.82) 20.26 (4.13) -.960 .340 
 
3.2.4.! Relationships between demographic variables and memory performance 
 
As age and educational attainment may be associated with memory performance, their 
relationship with AMT and 4MT scores were explored. Comparing performance 
between participants with and without university level education, the university 
educated group showed higher scores on the AMT (M=7.9, SD=1.80) than the non-
university educated group (M=6.74, SD=1.69) (t(67)=-2.425, p=.018, 95% CI -2.12- -
0.21, d=.66) There was no statistically significant difference between the groups on 
the 4MT scores (t(67)=.614, p=.614, 95% CI -1.60-2.70). There was no correlation 
between age and AMT scores, (r(67)=-.66, p=.593) or age and 4MT scores, (r(67)=-
.128, p=.293). 
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3.3.! Hypothesis testing 
3.3.1.! Primary hypothesis: Association between AMT scores and 4MT scores  
 
The primary hypothesis concerned the association between scores on the AMT and the 
4MT across both groups. Multiple regression analysis was conducted to establish 
whether depression status and 4MT scores predicted AMT scores. An interaction term 
between depression status and 4MT scores was included in the regression to 
investigate the potential of a moderation effect. The overall regression showed a 
significant effect in predicting AMT scores (F(3,68)=4.96, p=.004, R2=.19). However, 
the analysis showed that whilst depression status predicted AMT scores (β=-1.266, 
t(68)=-2.09, p=.041), scores on the 4MT did not (β=-.398, t(68)=-1.145, p=.256). The 
interaction term was not statistically significant (β=1.049, t(68)=1.453, p=.151), 
suggesting that the relationship between 4MT scores and AMT scores did not differ 
between the groups. There was no evidence of an association between 4MT and AMT 
scores, and the primary hypothesis was therefore not supported. 
 
3.3.2.! Hypothesis two: Difference in AMT scores between groups 
 
The second hypothesis aimed to replicate the findings of lower scores on the AMT in 
the depression group compared to the comparison group. The AMT scores and t-test 
results are presented in Table 4. There was evidence for a statistically significant 
difference between the clinical and the comparison group on scores on the AMT across 
both negative and positive cue words, with the depression group having lower scores 
on the AMT than the comparison group (t(67)=3.48, p=.01, 95% CI 0.61-2.25, 
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d=0.84). As the number of specific memories was lower in the clinical group compared 
to the comparison group, the second hypothesis was supported (Figure 2). 
 
 
Figure 2. Mean number of specific memories and standard deviations on the AMT in 
the depression and the comparison group 
 
To investigate influence of cue word valance on specificity, a mixed ANOVA was 
conducted with depression status as the between-subjects factor and valance as the 
within-subjects factor (Figure 3). The results showed an overall valance effect, with 
the mean number of positive specific memories being higher than the mean number of 
negative specific memories for both groups (F(1, 67)=10.66, p=.002), and an effect of 
group, confirming the higher number of specific memories in the depression group 
than the comparison group (F(1,67)=12.13, p=.01). The interaction between valance 
and group was not significant (F(1,67)=.419, p=.520), suggesting a similar valance 
effect in both groups. 
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Figure 3. Valance effects on number of specific memories in the depression and the 
comparison group 
 
3.3.3.! Hypothesis three: Difference in 4MT scores between groups 
 
The third hypothesis was that the depression group would have lower scores on the 
4MT than the comparison group. The 4MT scores and t-test results are presented in 
Table 4. There was  no evidence for a difference in scores between the depression and 
the comparison group and the third hypothesis was not supported (Figure 4). 
 
 
0
1
2
3
4
5
Depression3group Comparison3group
Nu
m
be
r3o
f3s
pe
ci
fic
3m
em
or
ie
s3o
n3
AM
T
Positive Negative
– 107 – 
 
Figure 4. Mean scores and standard deviations on the 4MT in the depression and the 
comparison group 
 
3.3.4.! Hypothesis four: Chronicity of depression and memory scores 
 
The fourth hypothesis was that earlier onset and longer duration of depression would 
be associated with lower memory scores on both the AMT and the 4MT. For the 
depression group, correlations were conducted using Spearman’s Correlation 
Coefficient between both AMT and 4MT scores and a number of clinical 
characteristics, including the length of current episode, number of past episodes, time 
since initial episode onset and BDI-II and GAD-7 scores. The results are presented in 
Table 5. There were no significant correlations found between either AMT or 4MT 
scores and any of the clinical variables, and the hypothesized association between 
chronicity of depression and autobiographical and spatial memory was not supported. 
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Table 5. Spearman’s Correlations between memory scores and depression variables  
Spearman’s Correlations between memory scores and depression variables (N=34) 
 AMT 4MT 
 ρ p value ρ p value 
Length of current episode .012 .946 .180 .308 
Number of previous 
episodes* 
-.045 .821 -.033 .869 
Time since initial onset -.022 .900 -.326 .060 
BDI-II score -.224 .203 -.308 .076 
GAD-7 score 0.16 .927 -.298 .087 
*Data missing for five participants 
 
In addition to testing the hypotheses about depression severity and performance on the 
memory tasks, t-tests were conducted to assess whether there were any differences in 
performance between participants taking anti-depressant medication and those who 
were not. No differences between the groups were found for the AMT (t(32)=.297, 
p=.768). For the 4MT, individuals taking anti-depressants had lower scores than those 
who did not take medication. However, when taking the Bonferroni correction for 
multiple testing into account, the results could not be considered statistically 
significant (t(32)=-2.096, p=.044, 95% CI -5.16- -.073). 
 
4.! Discussion 
 
4.1.! Summary of findings 
 
The aim of this study was to investigate the relationship between AM specificity and 
performance on a hippocampal-dependent ASM test in adults with and without 
depression. The primary hypothesis, that there would be an association between AM 
specificity and ASM performance, was not supported. The depression group recalled 
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fewer specific memories on the AMT than the comparison group, but there were no 
differences in ASM performance on the 4MT between the groups. There was no 
association between severity or chronicity of depressive symptoms and memory 
performance. 
 
4.2.! Is the memory deficit in depression specific to AM? 
 
This study replicated the findings of OGM in depression, with the identified effect size 
corresponding to past research (Liu et al., 2013; Ono et al., 2016). The results suggest 
that depression is associated with a specific memory deficit in AM that is not present 
in ASM. As both AM and ASM are dependent on the hippocampus, these results could 
further indicate that the observed deficits in AM do not reflect general hippocampal 
dysfunction (Eichenbaum & Cohen, 2014). Whilst this study failed to replicate past 
findings of impaired ASM in depression, it supports previous evidence that OGM 
cannot be explained by a general memory deficit in depressive disorders (Cornwell et 
al., 2010; Gould et al., 2007; Williams et al., 2007; Wong, 2015). Whilst some 
associations have been found between OGM and other forms of episodic memory, 
such as recognition, other studies have failed to find associations (Raes et al., 2006; 
Williams et al., 2007). Semantic memory is intact in depression, which has led to 
proposals that memory impairment is only present when recollection relies on the 
access to contextual details (Söderlund et al., 2014). However, given the lack of 
evidence of an impairment in ASM in this study, another possibility is that an 
impairment is present in memory tasks that involve emotional processing (Foland-
Ross & Gotlib, 2012). Recollection of AM can, depending on content, arguably be a 
painful process, and some definitions of AM have highlighted its contribution to 
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emotional regulation (Conway & Pleydell-Pearce, 2000; Köhler et al., 2015). A 
distinction can be made between “hot” and “cold” cognitive processes, with 
performance on “hot” tasks including emotional stimuli or processing (such as the 
AMT) possibly having a stronger relationship with depression compared to “cold” 
tasks that are less likely to trigger affective responses (such as the 4MT) (Gonda et al., 
2015; Miskowiak & Carvalho, 2014). Both the AMT and the 4MT are likely to rely 
on hippocampal function, but only the AMT involves self-relevant emotional 
processing.  
 
Conway and Pleydell-Pearce’s (2000) Self Memory System (SMS) model of AM 
offers an account of how emotional regulation can halt the retrieval of specific 
memories. The SMS suggests that deliberate AM retrieval occurs through the 
hierarchical activation of three different levels of AM, including lifetime episodes, 
categories of events, and event-specific knowledge. Conway and Pleydell-Pearce 
propose that the SMS can truncate searches to avoid retrieval of emotional event-
specific knowledge. OGM may represent a strategy for avoiding emotional content 
and regulate emotions in depression (Conway, Singer & Tagini, 2004; Raes, Hermans, 
Williams & Eelen, 2006). Williams and colleagues (2007) added to this hypothesis, 
suggesting that emotional and self-relevant retrieval cues may trigger rumination 
processes in depression, which can also contribute to the premature termination of AM 
retrieval. General executive function, which may be linked with the ability of the SMS 
to modulate memory retrieval, has also been linked with deficits in OGM (Dalgleish 
et al., 2007; Raes et al., 2006). The wealth of information needed for successful 
recollection of specific AMs, including self-reflection, emotion and imagery, may 
distinguish between AM and ASM performance in this study, and may implicate 
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distinct neural correlates independent of hippocampal function (Piolino et al., 2009; 
Svoboda et al., 2006). The emotional regulation hypothesis can provide an explanation 
as to why negative cue words were associated with a lower number of specific 
memories across both groups. The impairment in accessing specific AM in depression 
across both positive and negative words corresponds to the current literature and may 
reflect a global and indiscriminate avoidance function in depression (King et al., 2010; 
Liu et al., 2013). 
 
4.3.! Is OGM in depression associated with hippocampal function? 
 
The overlap of the neural structures involved in AM and depression has led to a 
compelling argument that OGM may be associated with hippocampal deficits. This 
study, however, found no association between OGM and performance on the 4MT, 
which has been shown to be sensitive to hippocampal impairment. Considering these 
findings, along with past neuroimaging studies yielding conflicting evidence for the 
association between OGM and differential hippocampal activation in depression, 
current support for a relationship between OGM and hippocampal dysfunction is 
modest (Hach et al., 2014; Young et al., 2012; 2013; 2014; 2015b; 2016). Whilst the 
hippocampus is a key structure in AM, other processes and structures may underlie 
OGM. If a key driver for OGM is affective, self-reflective and executive functions, its 
neural basis may include regions such as the prefrontal cortex and the amygdala 
(Levin, Heller, Mohanty, Herrington & Miller, 2007; Martinelli et al., 2013; 
Talarowska et al., 2016). King and colleagues (2010) suggest that whilst the 
hippocampus binds information into memories, the activation of the correct retrieval 
processes rely on the prefrontal cortex, which could suggest that OGM arises through 
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other cortical regions inhibiting hippocampal function during AM retrieval. Whilst this 
study has focused on hippocampal function and OGM, a full account of AM 
dysfunction can only be provided by considering the interactivity and connectivity 
between a large range of cortical regions (Piolino et al., 2009; Sheldon & Levine, 2016; 
Svoboda et al., 2006). 
 
Although the results of this study can be interpreted as OGM occurring in the absence 
of hippocampal neurogenesis, a number of other explanations should also be 
considered. Firstly, OGM may be linked with changes in hippocampal function that 
are not reflected in performance on the 4MT. The 4MT, along with other ASM tasks, 
have primarily been used in populations with well-established cognitive impairments 
(such as hippocampal damage and dementia), and may not be sensitive to the changes 
in cognition found in depression (Bird et al., 2010; Chan et al., 2016; Guderian et al., 
2015; Hartley et al., 2007; Moodley et al., 2015; Pengas et al., 2012; Wood et al., 
2016). One past study of depression found an association between depression and 
ASM measured by the Town Square Task (King et al., 2002), but not measured by the 
4MT (Wong et al., 2015). This study’s joint project, however, also failed to find an 
impact of depression on ASM using the Town Square Task, suggesting a lack of ASM 
deficits in the depression group across two hippocampal-dependent tasks (Williams, 
2017). Further, differences in neural activation may not always translate into 
behavioural differences between groups. For example, an fMRI study of associative 
memory and hippocampal activity in depression found that depression was associated 
with hippocampal dysregulation without observed differences in memory performance 
(Fairhall et al., 2010). The authors suggested that the hippocampal dysfunction may 
be presymptomatic, or counteracted by compensatory mechanisms. Two studies have 
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found increased activation in the hippocampus when specific memories were retrieved 
in depressed individuals compared to controls, and suggested that the increased 
activation may provide evidence for compensation of hippocampal atrophy (Young et 
al., 2014; 2016). Secondly, whilst neuroimaging studies have identified structural and 
functional hippocampal changes across the hemispheres, depression may be associated 
with dysfunction in sub-regions of the hippocampus that specialise in different 
memory functions (Burgess et al., 2002; McKinnon et al., 2009). Although there is 
significant overlap between the neural structures underlying AM and spatial memory, 
there is some support for specialisation across the longitudinal axis of the 
hippocampus, and between the left and the right hippocampus (Burgess et al., 2002; 
Fanselow & Dong, 2010; Iglói, Doeller, Berthoz, Rondi-Reig & Burgess, 2010; 
Sheldon & Levine, 2016). Sheldon and Levine (2016) suggest that the relative 
involvement of the anterior and posterior hippocampus depends on task demands, with 
the anterior hippocampus being preferentially involved in conceptual representations 
and the posterior hippocampus in perceptual representations. In line with this, they 
also suggest that the anterior hippocampus shows more involvement in open-ended 
memory retrieval tasks, whilst more well-defined memory tasks can rely on the 
posterior hippocampus. The specific deficit in AM compared to ASM in this study 
could hence reflect different task-demands between the AMT and the 4MT relying on 
different sub-regions of the hippocampus. Finally, trauma and PTSD have also been 
linked with changes in the hippocampus and with impaired ASM (Smith et al., 2015; 
Talarowska et al., 2016). As these were exclusion criteria of the study, participants 
may not have been representative of the adverse life events and stress often associated 
with depressive symptomology (Hammen, 2005). 
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4.4.! The links between depression severity, chronicity and memory 
 
This study found no associations between symptoms or chronicity of depression and 
OGM. Whilst there is some evidence for a link between number of depressive episodes 
and OGM, this corresponds with the general findings that OGM and other cognitive 
symptoms do not correlate with depression severity (Kuyken & Brewin, 1995; Liu et 
al., 2013; Reppermund, Ising, Lucae & Zihl, 2009; Williams et al., 2007). The 
cognitive features of depression may represent a categorical difference in processing 
and thinking styles, and a trait marker of depression rather than a mood-dependent 
state marker (King et al., 2010). However, the results of this study are only 
representative of individuals with depression onset at least 2.5 years prior to testing, 
and currently experiencing at least moderate symptoms of depression. Within the 
depression group, there was a trend towards time since initial onset, BDI-II scores, 
GAD-7 and medication use being associated with lower scores on the 4MT. If 
cognitive changes were associated with dysregulation of the HPA-axis and the impact 
on the hippocampus, a dose-response relationship between chronicity and memory 
deficits on the 4MT could be predicted. Given that this was a trend rather than an 
association of statistical significance, and that no differences were found in 
performance on the 4MT between the depression and comparison groups, it is not 
possible to draw any conclusions based on this data. 
 
4.5.! Clinical and theoretical implications 
 
Understanding OGM and other memory deficits in depression is important due to their 
potential consequences on functioning, well-being and the course of the disorder 
– 115 – 
(Sumner et al., 2010; Williams et al., 2007). High levels of OGM may also interfere 
with the engagement in and the success of treatment (Etkin, 2016; Köhler et al., 2015; 
Talarowska et al., 2016). Current pharmacological and psychological treatment 
strategies for depression mainly target the emotional features of the disorder, whilst 
the cognitive features are often not recognised or addressed (Darcet et al., 2016, Gonda 
et al., 2015; Hammi et al., 2014). As this study replicated the finding of OGM in 
depression being present within a population of service-users of the NHS IAPT 
services, it could provide support for improved recognition and treatment of memory 
deficits in chronic depression.  
 
The lack of an association between OGM and ASM in this study provided no evidence 
for integrated theories of hippocampal involvement in AM and ASM. Given the vast 
evidence-base for the hippocampal involvement in both, however, this absence of 
evidence should not be interpreted as evidence of an absence in the association 
between the neural underpinnings of the two types of memory (Eichenbaum & Cohen, 
2014). It should also be noted that the power calculation and sample size of this study 
only allowed for detection of a moderate effect size with 80% power.  
 
4.6.! Limitations 
 
A number of limitations of this study should be considered when interpreting the 
results. 
 
Firstly, whilst no differences were identified in terms of demographic variables, it is 
possible that the motivations for research participation differed between the groups 
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which could have led to differences in the two samples. Secondly, the 
representativeness of both groups should be considered. The results in the depression 
group should only be regarded as representative of individuals with at least moderate 
symptoms of depression, a history of depression of more than 2.5 years. In addition, a 
third of the participants screened for the depression group were excluded from 
participation, mainly due to potential co-morbidities. Despite the symptom severity 
and chronicity, the majority of participants in the depression group were highly 
functioning in regards to employment status and income, which is not representative 
of all individuals with depression. A number of participants in the depression group 
also reported an interest in the study due to subjective memory problems, which may 
have led to selection bias in the recruitment.  
 
Thirdly, the validity and reliability of the measurement tools in this study should be 
considered. Whilst the AMT is considered the gold standard method of measuring 
OGM, it is a testing paradigm rather than a standardised measurement tool (Liu et al., 
2013). The AMT is considered to have adequate psychometric properties, but studies 
have used a range of different variations, and it is possible that features of the 
administration such as cue words used, time limit and task instructions can influence 
participant performance (Griffith et al., 2012; Yanes, Roberts & Carlos, 2008). The 
study did also not measure remoteness or qualitative aspects of memory retrieval, such 
as subjective vividness, detail, emotional arousal or perceptual features, which may be 
associated with distinct neural regions (Addis, Moscovitch, Crawley & McAndrews, 
2004; Falco, Peynircioglu & Hohman, 2015; St-Laurent, Moscovitch & McAndrews, 
2016; Piolino et al., 2009). The 4MT has similarly not had its psychometric properties 
formally evaluated, and it is possible that the 4MT is not sensitive enough to identify 
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hippocampal deficits in depression. This study used the version of the 4MT that only 
includes allocentric memory trials (Hartley & Harlow, 2012), and the use of the 
original tasks which calculates a score between non-spatial and ASM as an index of 
hippocampal function could have potentially provided a more sensitive measure, 
especially given previous null findings in depression using the 4MT (Hartley et al., 
2007; Wong et al., 2015). The 4MT was also used as a measure of overall hippocampal 
function, rather than considering the potential functional specialisation of regions of 
the hippocampus. Depression history was measured using self-report questions, and a 
number of participants found it difficult to provide accurate answers, which may have 
impacted the reliability of the data. Measures of current state, such as tiredness, or task 
effort, were not included. A challenge in depression research is the heterogeneity of 
presentations, and further exploration of other cognitive symptoms could have 
provided useful information about current symptomology. This, however, was not 
possible within the scope of this project.  
 
Lastly, the cross-sectional design of this study meant that it could not address the lack 
of knowledge about the causal relationships or aetiology between the measured 
variables (Darcet et al., 2016; Gonda et al., 2015). 
 
4.7.! Conclusions and future directions 
 
This study replicated the presence of AM deficits in depression. There was no support 
for deficits in hippocampus-dependent ASM, or evidence for an association between 
OGM and ASM. Whilst this can be interpreted as a lack of support for hippocampal 
deficits underlying OGM in depression, this conclusion may be premature due to the 
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potential lack of sensitivity to detect hippocampal function in depression in the 
measure used. It does, however, highlight the need for further investigation to 
understand both the affective, cognitive and neural correlates of OGM. Whilst both 
neuroimaging and behavioural measures of hippocampal function have their 
limitations, they can be used to complement each other in future research (Fairhall et 
al., 2010; Svoboda et al., 2006). There are strong reasons to believe that the cognitive 
features of depression have structural and functional neural correlates, and much 
potential for research in this area. As these are currently not well understood, there is 
great potential for further research in this area.  
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1.! Introduction 
 
The aim of the critical appraisal was to undertake and provide reflections on the 
process of conducting this research project. From the initial thoughts and ideas to the 
write-up phase, this process has spanned over two years, offering vast opportunities 
for learning and reflection. In this section, I will focus on the topics that have been 
most thought-provoking or that have had the most tangible impact on my professional 
development during the course of the project. I will discuss the benefits of conducting 
a joint project, challenges with the exclusion criteria and generalisability, limitations 
of the Autobiographical Memory Test (AMT), and also reflect on the implications of 
taking on a clinical research role within the National Health Service (NHS). More 
general considerations, relating to study design and recruitment of participants, will be 
considered under several of these headings. 
 
2.! Benefits of a joint project 
 
As a third year trainee clinical psychologist, you are frequently asked by trainees in 
earlier stages of the course what to think about when selecting a major research project. 
My response to such questions has invariably been “Have you considered a joint 
project?”.  
 
My choice of project at the time, however, was not based on the fact that it was a joint 
project arrangement. Rather, what triggered my interest was my experience of working 
with depression and the appreciation of the vast heterogeneity within this diagnostic 
category. It is often cited that the current diagnostic criteria for depression allow for 
two individuals with no overlapping symptoms to receive the same diagnosis (APA, 
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2013). Limitations and variability in treatment responses reflect the need for increased 
understanding of the affective, cognitive, biological and social factors involved in 
depression. It was my hope that I with this project would be able to make my own 
contribution to the knowledge base by shedding some additional light on the memory 
features associated with the disorder. My specific interest in autobiographical memory 
(AM) originated from my undergraduate thesis on memory and eating pathology. The 
fact that I ended up having a research partner, was a lucky coincidence based on shared 
interests.  
 
Whilst I was very open to the idea of a joint project from the outset, I did not appreciate 
all the benefits until much later in the process. In practical terms, recruitment and data 
collection was very time-consuming, and a sample of 69 participants could only be 
achieved through a joint project. The consensual decision-making and problem-
solving, and the opportunity to fine-tune various aspects of the research through an on-
going dialogue with my project partner (in addition to my supervisor), definitely 
benefitted the final research design.  
 
Another big advantage of being part of a joint project was the mutual support and the 
informal peer-supervision we could provide to each other on a continuous basis. It is 
not without reason that the major research project component of the Doctorate in 
Clinical Psychology is seen as a strenuous task, and the pressures of post-graduate 
studies are reflected in high stress-levels in this population (Hyun, Quinn, Madon & 
Lustig, 2006). The joint project arrangement helped me manage both the daily stress 
and the occasional feelings of despondency. It is, of course, textbook knowledge that 
social support is a powerful buffer between stress and distress (Cohen & Wills, 1985). 
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Indeed, studies have demonstrated the benefits of social support, and emotional focus 
and venting as a coping strategy, specifically in psychology graduate students (Myers 
et al., 2012; Nelson, Dell’Oliver, Koch & Buckler, 2001). Having a project partner 
also opened a path for discussing small dilemmas and interactions with research 
participants, which would not have been appropriate to do with individuals outside the 
project, and equally would not always have met my personal threshold for contacting 
my project supervisor. At times where there were challenges, for instance with slow 
recruitment, sharing this helped me maintain an overall positive attitude.  
 
Whilst the joint project was an overwhelmingly good experience, it does, of course, 
also involve a risk of interpersonal difficulties. After some reflection, I believe that the 
key to our successful cooperation was free and open communication and a practical 
approach to the tasks of the study. All tasks were not divided exactly equally at all 
times, but we worked in tandem towards the joint goal of finishing the project. The 
importance of good interpersonal relationships when conducting research was also 
highlighted by the invaluable support we received from staff working in the services 
where the depression group was recruited, not to mention the excellent support I 
received from my research supervisor throughout the process.  
 
It is also worth mentioning that the joint project arrangement had an impact on the 
design of the study as it was based on a balance between the aims and the needs of two 
projects. In a single project it would have been possible to investigate the association 
between AM and spatial memory using two measures rather than one, but to keep a 
clear distinction between the projects we did not use the other project’s spatial memory 
data for analysis. In addition, the testing time for the measures of both projects was 
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about 75 minutes, and limiting the time-demands on participants required careful 
planning and consideration of the tasks and measures to be included. The decision to 
use the standard ten cue word AMT with a 30 second time-limit, for instance, was 
largely based on the practical consideration that administration of other versions would 
have been more time-consuming. Balancing the needs of the two projects also meant 
that it was not possible to include other measures that might have provided interesting 
information, such as scales of rumination. In retrospect, due to the established 
association between OGM and general intellectual functioning and working memory, 
it would have been useful to include a measure to establish whether there were 
differences between the groups in these abilities (Heron et al., 2012; Raes et al., 2006; 
Wessel, Merckelbach & Dekkers, 2002). 
 
3.! Exclusion criteria and the effects on generalisability 
 
This project has made me appreciate the challenges of determining and screening for 
inclusion and exclusion criteria in clinical research. The exclusion criteria of this study 
were based on factors that may have influenced memory performance independently 
of depression status. Due to practical limitations, some of the screening procedures for 
the exclusion criteria, however, somewhat lacked sensitivity and specificity. For 
example, the exclusion of participants for alcohol or substance abuse was based on a 
self-report question and not on a standardised scale. On the other hand, the use of 
psychiatric screening questions from the Structured Clinical Interview for DSM Axis 
I Disorders (SCID-I) (First, Spitzer, Gibbon & Williams, 1996) may have excluded 
participants with no actual psychopathology. It is also worth noting that the inclusion 
criteria for the depression group were based on the presence of symptoms of 
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depression rather than on a confirmed diagnosis. Additional exclusion criteria may 
also have been warranted. For example, one participant reported a medical condition 
influencing their memory and was therefore excluded, even though the set screening 
procedure did not specifically address this. In addition, whilst a third of the participants 
screened for the depression group did not meet the eligibility criteria for the study, this 
was only the case for two participants in the comparison group. Indeed, the presence 
of co-morbid psychiatric problems is likely to be much higher in the depression group, 
but it also seems unlikely that only two participants in the comparison group actually 
met the exclusion criteria. This could be interpreted as a failure of the screening 
procedure to capture the exclusion criteria, but perhaps also reflects different 
motivations for participation and eligibility between the two groups. Calling the non-
depressed group a “comparison” rather than a “control” group was a conscious 
decision as I do not think the two groups were perfectly matched across all features 
and characteristics.  
 
In addition, the impact of the inclusion and exclusion criteria on the external validity, 
or generalizability, of studies should be considered. This is relevant to the data 
collection in the empirical study, but also to the studies included in the literature 
review. Treatment studies for depression are often criticised for their narrow inclusion 
criteria and for excluding participants with co-morbid psychiatric symptoms (Stirman, 
DeRubeis, Crits-Cristoph & Brody, 2003). For example, the exclusion criteria used in 
most anti-depressant research implies that only around 15% of those seeking support 
for depression meet the eligibility criteria for participation in randomised controlled 
trials (Zimmerman, Mattia & Posternak, 2002). Similar problems with selection bias 
apply to cross-sectional research, including this study, where the exclusion of 
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participants with co-morbid symptomology potentially leads to less complex 
depression samples than those found in the actual population. In retrospect, excluding 
participants based on potential symptoms of obsessive-compulsive disorder (OCD) is 
unlikely to have been a useful criterion, in particular given that general symptoms of 
anxiety were not screened for. I would now reconsider this exclusion criterion. This 
could potentially have facilitated the recruitment of the depression group, which was 
very lengthy, partially due to strict eligibility criteria. In addition, not excluding 
participants based on trauma history or potential symptoms of post-traumatic stress 
disorder (PTSD), and instead including relevant symptom measures in the study, could 
have provided additional information about the links between depression, life events, 
memory and hippocampal function. Due to the exclusion criteria, the depression group 
in this study is likely to have experienced less trauma than would usually be expected 
in a depression sample.  It is possible that whilst depression is independently associated 
with deficits in AM, deficits in spatial memory may be particularly associated with the 
emotional and neurological reactions to trauma-exposure (Smith, Burgess, Brewin & 
King 2015). Including trauma symptoms measures, however, was not pursued, partly 
due to practical limitations, and partly due to the additional ethical considerations 
required when asking more detailed questions about trauma and PTSD.  
 
Whilst the question of generalizability of findings is of key importance, the ethical 
implications of excluding participants from research, and hence preventing them from 
contributing to the evidence-base of the symptoms they are experiencing, should also 
be considered. Whilst most excluded participants reported no questions or concerns 
about not meeting eligibility criteria for the study, two voiced frustration with not 
being able to take part due to psychiatric history or demographic features, both 
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reporting a feeling of being “dismissed” by clinical research. Whilst the theoretical 
reasons for excluding participants can be defended, I can also empathise with service-
users feeling excluded from research they find relevant to themselves. There is perhaps 
an argument to be made about decision about research eligibility being too clinician-
led, and that this study, like many others, would have benefitted from more service-
user input across different stages of the research. 
 
4.! Validity and reliability of the Autobiographical Memory Test 
(AMT) 
 
The AMT is the dominant measure for AM specificity and overgeneral memory 
(OGM) (Liu, Li, Xiao, Yang & Jiang, 2013; Williams et al., 2007). The reliance on 
the AMT as a measure of OGM in both the literature review and the empirical study 
of this paper, however, warrants some considerations of its weaknesses.  
 
For the purpose of the literature review, the AMT was rated as a high-quality 
measurement tool in terms of validity and reliability. This decision was largely 
pragmatic, and based on the research question assuming that OGM is a measurable 
construct. However, this could be challenged both based on evidence that different 
modes of administration could affect the results, and on the validity of the AMT as a 
measurement tool (Liu et al., 2013).  
 
Regarding the validity of the AMT, it should be considered what exactly the AMT 
measures. The underlying assumption in the OGM literature is that the AMT provides 
a measure of AM retrieval, and that this is of clinical relevance to the onset, 
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maintenance and course of depression (Conway & Pleydell-Pearce, 2000; Griffith et 
al., 2012; van Vreeswijk & de Wilde, 2004; Williams et al., 2007). Whilst current 
evidence suggests that the AMT measures an independent feature of depression, the 
links to other features and correlates of depression, such as rumination, executive 
function, avoidance and trauma, highlights the possibility that the outcomes of the 
AMT may represent a variety of both independent and interdependent processes 
(Griffith et al., 2012; Williams et al., 2007). It should also be made explicit what the 
AMT is not measuring. Studies have, for example, demonstrated a distinction between 
specificity and detail in autobiographical memories, as well as specific memories 
differing substantially on features such as the subjective experience of remembering 
(Kyung, Yanes-Lukin & Roberts, 2016; Piolino, Desgranges & Eustache, 2009). The 
validity of the AMT is also challenged by the over-reliance of a single measure of 
OGM (Williams et al., 2007; Sumner, Mineka & McAdams, 2013). The most widely 
used version of the AMT is the original version that initially identified and labelled 
the OGM phenomenon (Williams & Broadbent, 1986). There is a lack of studies 
investigating OGM using several different measures of AM within the same sample, 
which could strengthen the validity of the AMT as the gold standard measure for 
memory specificty (Sumner et al., 2013). 
 
The stability of OGM, and whether the AMT measures a trait or a state feature of 
depression, has also been debated (van Vreeswijk & de Wilde, 2004). Studies 
examining AM at different points in time have suggested that OGM is a relatively 
stable trait when measured at monthly intervals, but the association is modest over 
time-periods of several years (Griffith et al., 2012; Sumner et al., 2014). This 
highlights the importance of controlled and randomised clinical trials as some variation 
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is to be expected in the absence of any intervention. The learning effect on performance 
on the AMT is currently unclear, and a problem in the literature review included 
several studies not reporting whether they used the same cue words during 
administration at different time-points.  
 
Evidenced by the studies in the literature review, a number of different administration 
procedures and cue words have been used for the AMT. Across a number of versions, 
the investigation of the psychometric properties of the AMT suggested good internal 
consistency and that the AMT had a unifactorial structure, with emerging evidence for 
these properties applying across different languages and cultural backgrounds (Griffith 
et al., 2009; Heron et al., 2012; Takano, Mori, Nishiguchi, Moriya & Raes, 2017). 
Compared to more in-depth and resource-intensive ways of assessing autobiographical 
memory (such as semi-structured interviews), it offers a measure that is relatively easy 
to administer and provides data that can be reliably coded (Griffith et al., 2012; Heron 
et al., 2012).  
 
Memory specificity may be associated with administration features of the AMT, 
including the number of cue words, time allowed for retrieval, the methods of 
recording responses, and whether prompting is used (Liu et al., 2013). It has also been 
proposed that OGM in depression may be a result of poor recollection of task 
instructions (Yanes, Roberts & Carlos, 2008). In non-clinical populations, however, 
detailed task-instructions may decrease the sensitivity of the AMT and produce ceiling 
effects in the data, and it has been proposed that an AMT with minimal instructions 
offers the most sensitive way of measuring OGM in non-clinical populations (Deeber, 
Hermans & Raes, 2009). In this study, the standard AMT procedure (which includes 
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detailed instructions, examples and prompting) was used (Williams & Broadbent, 
1986). The use of more detailed instructions and prompting increases the risk of 
researcher bias, which is relevant to this study as the researchers were not blind to 
participant condition (van Vreeswijk & de Wilde, 2004). Liu and colleagues (2013) 
have suggested that the AMT is most sensitive when 15 cue words are used, and 
participants are given 60 seconds to retrieve a memory. Based on their meta-analysis, 
the use of 10 cue words in this study could have underestimated OGM, whilst the 30 
second retrieval time may have overestimated it by not giving depressed participants 
enough time. Griffith and colleagues (2012) suggest that efforts should be made to 
establish a more standardised version of the AMT to facilitate comparison across 
studies. Notwithstanding, it is also possible that different populations and 
measurement purposes warrant different versions. 
 
Lastly, the AMT is considered as a measure of memory retrieval, but memory 
encoding may also be impacted by depression and influence performance on the AMT 
(Harvey et al., 2016). Considering effects of depression on encoding was out of the 
scope of this thesis, but could also be associated with differences in neurological 
patterns or responses to interventions for depression (Harvey et al., 2016; van 
Eijndhoven et al., 2011). 
 
5.! Reflections on the different roles of a trainee clinical 
psychologist 
 
When balancing the plural roles of a trainee clinical psychologist in the NHS, I have 
found the analogy of “wearing different hats” helpful (May, 1978; Leavitt, Reynolds, 
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Barnes, Schilpzand & Hannah, 2012; Resnikoff & Lapidus, 1990). This project was 
my first experience of wearing a “researcher hat” in the context of depression. Whilst 
many aspects of this role drew on my therapeutic skills, I am more experienced and 
comfortable as a therapist than as a researcher. My new professional role (or hat) did 
therefore not always feel entirely comfortable.  
 
The nature of the depression questions used in this research often prompted 
participants to further elaborate on their depression history and their current context 
and difficulties. These interactions sometimes tempted me to replace my “researcher 
hat” with my “therapist hat”, and to further engage in a therapeutic conversation. 
Arguably, however, this would not have been in conformity with my research role, and 
any attempt on my side to provide a therapeutic intervention would have been 
inappropriate as I lacked both the information needed for a formulation and the time 
and resources for an intervention. It was a good to know that all participants with 
depression were currently receiving psychological support. However, throughout the 
data collection, I became more confident as to which psychological support skills 
would fit under my “research hat”, such as empathic listening, and sometimes 
reflecting back dilemmas or strengths present the participant narratives. This 
sometimes also included some basic psychoeducation about depression, such as 
normalising symptoms. I also believe that a number of participants found the topic of 
the study normalising of their cognitive symptoms, as several people mentioned that 
they considered memory and attention problems as part of their depression.  
 
I wonder whether participants perhaps also found it difficult to clearly distinguish 
between their roles as patients or clients from that of research participants. Importantly, 
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all the data collection for the depression group took place at the local mental health 
services, which may have blurred this distinction. I did therefore find it important to 
listen and validate participant experiences, as a dismissive attitude could have 
impacted their relationship with the service or their inclination to seek help later (Reder 
& Fredman, 1996).  
 
Whilst the aims of the researcher sessions were very different from therapeutic work 
with depressed individuals, this experience has made me understand which of my skills 
are perhaps best conceptualised under a general “clinical psychologist hat” rather than 
a “therapist hat”, and also made me more comfortable applying these skills in a new 
and different setting. 
 
6.! Conclusions and final comments 
 
Conducting this research project, which spanned over two years, offered me insight 
into some of the theoretical and practical challenges associated with clinical research 
and gave me a range of new skills. Particularly, it has helped me understand the 
complexity and the need to strive for balance between different priorities within a 
study. This knowledge and understanding will not only help me when conducting 
future research, but also when reading and interpreting published studies.  
 
This project was based on literature about depression, memory and the human brain. 
Despite the vast amount of research and theories available across these topics, they all 
represent areas of human functioning where there are perhaps still more questions than 
answers. As science has increasingly managed to map out the complexities of the 
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human body and address physical disease, mental health problems such as depression 
have become the main contributors to disability in many parts of the world, which 
highlights the importance of taking our understanding of its features further to inform 
prevention and treatment strategies (World Health Organisation, 2017). I look forward 
to seeing how our knowledge and conceptualisation of depression will develop 
throughout my career as a clinical psychologist. 
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Appendix A:! Details of stages of research conducted individually 
and jointly 
 
 
Individual Joint Comments 
Literature Review √   
Empirical paper     
Research question √   
Research design  √ √ Initially individual, with collaboration on 
the final design and procedures 
Ethical approval   √ Tasks conducted jointly or shared  
Liaison with IAPT services  √ Tasks conducted jointly or shared 
Participant recruitment  √ Tasks shared 
Participant testing  √ Tasks shared 
Data scoring and input   √ Tasks shared 
Data analysis  √   
Write-up √   
Critical appraisal  √   
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Appendix B:! Details of measures used in joint project 
 
 
Joint 
Individual: Janice 
Williams’ project 
Individual: Line 
Sågfors’ project 
Beck Depression Inventory II (BDI-
II) (Beck, Steer, Ball & Ranieri, 
1996) 
√   
Generalised Anxiety Disorder – 7 
(GAD-7) (Spitzer, Kroenke, Williams 
Lowe, 2006) 
√   
Bespoke clinical information 
questionnaire 
√   
Demographic information √   
Ten Item Personality Measure (TIPI) 
(Gosling, Rentfrow & Swann, 2003) 
 √  
Town Square Test  
(King, Burgess, Hartley, Vargha-
Khadem & O’Keefe, 2002) 
 √  
Four Mountains Test  
(Hartley et al., 2007) 
  √ 
AMT (Williams & Broadbent, 1986)   √ 
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Appendix D:! NHS Ethical Approval of Substantial Amendment 
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Appendix E:! Participant information and consent form for 
depression group 
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Appendix F:! Participant information and consent form for 
comparison group 
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Appendix G:! Researcher script  
 
1.! Introduction  
 
Here is a sheet that has some information about the study. Please read through it 
and ask me any questions you may have (or go through it with them).  
 
You will get paid 12.5 when you have completed the tasks.  
 
Opportunity to ask questions.  
 
2.! Questionnaires  
 
Demographics (participant to fill in)  
 
BDI (participant to fill in) CLINICAL GROUP ONLY 
 
GAD-7 (participant to fill in) CLINICAL GROUP ONLY  
 
Depression questions (interview) CLINICAL GROUP ONLY 
 
Ten Item Personality Inventory (TIPI) (participant to fill in) CONTROL GROUP 
ONLY  
 
3.! AMT  
 
In this task, we will ask you to remember events from the past and describe them in a 
sentence or two. We will then ask you to write this sentence down.  
 
I am going to give you a number of different words. For each word, we want you to 
think of an event that happened to you which the word reminds you of. I will read 
you the word, and you will also see it in this booklet. The event could have happened 
recently or a long time ago. It might be an important event, or trivial event. Once you 
have thought of the event, we would like you to describe the event in a sentence or 
two.  
 
The memory you tell us should be a specific event – an event that lasted less than a 
day, and occurred at a particular time and place.  
 
It is important to try to tell us a different memory or event for each cue word. If you 
cannot think of a memory within a specified amount of time, we will move to the next 
cue word. I will write down your answers.  
Let me give you an example: If the word was ‘enjoy’, “I always enjoyed a good 
party” would not be a specific memory because it does not mention a particular time, 
but saying “Jane’s party last Friday” would be a specific memory.  
– XXIII – 
Practice trials to confirm that the participant has understood the instructions 
(results not used in analysis):  
 
Let’s try a couple of practice words before we get started. Please first tell me the 
memory, and I will then ask you to write it down.  
 
Please think of an event that this word reminds you of (provide word verbally and 
present cue card):  
 
•! Relieved  
 
•! Tired  
 
That’s exactly the sort of thing we are looking for – that is a specific memory 
because it refers to a particular event.  
 
Give participant more than 30 seconds if needed.  
If participant recalls a memory that is non-specific, prompt for a specific memory: 
Can you think of a specific time – one particular episode? 
 
If participant is not able to think of a specific memory – provide example: So an 
example of a specific memory here could be “When I passed my driving test” 
(relieved)/ “Yesterday when I got home from work (tired).  
 
 
Autobiographical memory test  
 
Okay, let’s get started with the task. If you cannot recall a memory within the 
specified amount of time, we will move to the next cue word. Please first tell me the 
memory and then write it down. Please don’t turn to the next page in the booklet 
until I ask you to do so.  
 
Time limit for retrieval – 30 seconds. Record time taken for retrieval.  
 
Please think of an event that this word reminds you of (provide word verbally and 
present cue card) 
  
If not specific: provide prompt - Can you think of a specific time—one particular 
episode? 
 
•! Happy  
 
 
•! Sorry  
 
 
•! Safe 
 
 
•! Angry 
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•! Interested 
 
 
•! Clumsy 
 
 
•! Successful 
 
 
•! Hurt (emotional) 
 
 
•! Surprised  
 
 
•! Lonely  
 
Thank you - that is the end of the task.  
 
If long descriptions: That is great – but you only have to give a very short 
description. One or two sentences is enough.  
 
 
4.! Spatial memory task I – 4 mountains  
 
(START AT SLIDE 1) We’re going to do a test that requires you to look at pictures of 
landscapes with mountains in them (SHOW SLIDE 2) . Before we start the test we’ll 
do some practice examples, so please don’t mark your response sheets at this stage 
until I tell you the main test is beginning. When you first hear about it, the test might 
sound easy, but most people find it quite difficult, so it is important to listen carefully 
to the instructions”  
 
(CHANGE TO SLIDE 3) First you will see a picture of one landscape with 
mountains. The next slide will show four similar pictures seen from different points 
of view and under different conditions, as if taken at different times of the year and 
times of the day.” (SHOW SLIDES 3) 
 
“One of the pictures in the second slide will show exactly the same place as the one 
in the first, although it will be shown from a different viewpoint. Your task is to 
identify which of the four pictures shows the same place as the first picture.” 
 
“The test is hard, because when you first see the mountains you cannot guess where 
you will next see them from, so it is important to focus on their layout which doesn’t 
change.  
The shadows and clouds and the patterns of colour on the ground don’t help because 
they might change when you view the place from another direction at another time of 
day or year.” 
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Let’s see what the test will look like: 
 
“Here you have a picture of a mountain landscape. (SHOW SLIDE 4) 
 
Try to focus on the layout of the scene – so concentrate on the shape and 
arrangement of the mountains relative to each other.  
 
[Wait for 10 seconds] 
 
Now here are four pictures to choose from. Which one of these shows the same place 
as the one in the previous slide? Work out your answer but don’t write anything 
down.” (SHOW SLIDE 5) 
 
[Wait a few seconds while participants think about it.] 
 
[Show next slide.] 
 
“if you thought it was this one [indicate yellow highlighted picture] you are right. In 
each of the other pictures the layout of the mountains is different. (SHOW SLIDE 6) 
 
For example, in this picture [indicate picture with red arrows] these two hills are 
closer together than in the first picture, and there are other differences. (SHOW 
SLIDE 7) 
 
We’ll do a few more practice questions now. After each practice item, you will be 
shown the correct answer, and the original picture you looked at – take a moment to 
see whether you were right or wrong. If you were wrong try to figure out why the 
answer you chose did not match the correct one. In the main test, you will not find 
out about the right and wrong answers, so this is a good chance to make sure you 
have understood the instructions. 
 
PRACTICE 1: SLIDES 8 – 9 – 10 - 11 
 
PRACTICE 2: SLIDES 12 – 13- 14- 15 
 
PRACTICE 3: SLIDES 15 – 16  
 
There are 30 items in the test, and for each item you will have ten seconds to study 
the first picture and then 20 seconds to choose which of the four pictures on the next 
slide shows the same place. When you have decided which of the four pictures shows 
the same place – mark your response sheet. Each numbered item there is a grid of 
four boxes – tick the box corresponding to the picture you have chosen, so if the top-
left picture shows the same place, you would mark the top left box for that question. 
If you are not sure, you should just make the best guess you can in the time available. 
 
The main test begins in just a moment. Please get ready to start marking your 
response sheet. 
 
 
5.! Spatial memory task II – Town Square  
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See separate form  
 
6.! Word ratings  
 
See separate form  
 
7.! Debriefing and payment (remember signing!) 
 
That is the end of the tasks. Thank you so much for participating. Do you have any 
questions?  
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Appendix H:! Acronyms and abbreviations 
4MT Four Mountains Test  
AM Autobiographical Memory  
AMS Autobiographical Memory Specificity 
AMT Autobiographical Memory Test 
ASM Allocentric Spatial Memory  
BDI II Beck Depression Inventory II 
BOLD Blood Oxygen Level Dependent 
CA3 Cornu Ammonis region 3 
CaR-FA-X Capture and Rumination – Functional Avoidance – eXecutive 
function  
CBT Cognitive Behavioural Therapy 
CCT Controlled Clinical Trial 
ECT Electro-Convulsive Therapy  
EPHPP Effective Public Health Practice Project 
fMRI Functional Magnetic Resonance Imaging  
GAD-7 Generalised Anxiety Disorder scale 7 
HPA Hypothalamic Pituitary Adrenal  
IAPT Improving Access to Psychological Therapies 
LRT Life Review Therapy  
MBCT Mindfulness-Based Cognitive Therapy  
MemFlex Memory Flexibility  
MeSH Medical Subject Heading 
MeST Memory Specificity Training  
NHS 
OCD 
National Health Service 
Obsessive-Compulsive Disorder  
OGM OverGeneral Memory 
PHQ-9 Patient Health Questionnaire 9 
PTSD Post-Traumatic Stress Disorder 
RCT Randomised Controlled Trial 
ReSSI Relapse Signature of Suicidality Interview 
SCEPT Sentence Completion for Events from the Past Test 
SCID-I Structured Clinical Interview for DSM Axis I Disorders 
SMS Self Memory System  
TAU Treatment As Usual  
UCL University College London 
 
 
